Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certfified Pharmacy Executive Leader (CPEL)
Integrated Informatics Institute
Full Poster Schedule
Home
Full Poster Schedule
All Days
Sun, Dec 3
Mon, Dec 4
Tue, Dec 5
Wed, Dec 6
Full Poster Schedule
Type here to filter the list
Tuesday, December 5, 2023
10:45 AM – 11:45 AM
Student Posters
10:45 AM – 11:45 AM
(6-001) Comparison of Peer, Self, and Faculty Objective Structured Clinical Examination Evaluations in a PharmD Nonprescription Therapeutics Course
Favorite
10:45 AM – 11:45 AM
(6-002) Let The Lead Out: Treatment of Lead Toxicity in Pediatric Patients
Favorite
10:45 AM – 11:45 AM
(6-003) Drug-Induced Angioedema After Switching from Lisinopril to Sacubitril/Valsartan
Favorite
10:45 AM – 11:45 AM
(6-004) Treatment of severe menorrhagia in an 11-year-old pediatric patient
Favorite
10:45 AM – 11:45 AM
(6-005) Review of current basal insulin prescriptions and evaluation of overbasalization rates in a family medicine residency clinic
Favorite
10:45 AM – 11:45 AM
(6-006) Development and Implementation of an Interactive Precepting Simulation for Student Pharmacists
Favorite
10:45 AM – 11:45 AM
(6-007) Unraveling the Diagnosis of Drug Induced Lupus in a Pediatric Patient with Crohn’s Disease
Favorite
10:45 AM – 11:45 AM
(6-008) Impact of Appropriate Oral Anti-cancer Medication Monitoring on Treatment Failure
Favorite
10:45 AM – 11:45 AM
(6-009) Negative Predictive Value of Methicillin-Resistant Staphylococcus aureus (MRSA) Nares PCR for Extrapulmonary Infections in Critically Ill Patients
Favorite
10:45 AM – 11:45 AM
(6-010) Single-Center Analysis of Intravenous Tacrolimus Use in the Prevention of Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplant
Favorite
10:45 AM – 11:45 AM
(6-011) Albumin Use for Resuscitation in Trauma Patients
Favorite
10:45 AM – 11:45 AM
(6-012) From Awareness to Action: The Role of Opioid REMS Education in Safer Pain Management and Opioid Prescribing
Favorite
10:45 AM – 11:45 AM
(6-013) Pharmacy Practice in Prague: Descriptive Analysis and Qualitative Interviews of Czech Pharmacists and Patients
Favorite
10:45 AM – 11:45 AM
(6-014) Student Pharmacist Led Vaccination Against Influenza at a Free, Community Clinic in North Carolina
Favorite
10:45 AM – 11:45 AM
(6-015) Assessing Appropriateness of Protamine Prescribing, Administration, and Adverse Drug Events.
Favorite
10:45 AM – 11:45 AM
(6-016) Participant perspectives on a pharmacy student Longitudinal Patient Experience Program: a qualitative analysis
Favorite
10:45 AM – 11:45 AM
(6-017) Characterization of Pharmacist Interventions Performed During Discharge Medication Reconciliation
Favorite
10:45 AM – 11:45 AM
(6-018) Monotherapy with Mood Stabilizers or Antipsychotic Agents vs Combination Pharmacotherapy Impact on 30-day Hospital Readmission for Mania in Bipolar Disorder
Favorite
10:45 AM – 11:45 AM
(6-019) Pharmacy Dashboard Review and Optimization of High-Cost Medications at a Family Medicine Clinic
Favorite
10:45 AM – 11:45 AM
(6-020) Vancomycin Area Under the Curve (AUC) Target Attainment in Obese Patients
Favorite
10:45 AM – 11:45 AM
(6-021) Usage of Prophylactic Bowel Regimens for Adult Patients on Opioid Therapy in the Surgical Unit at New Hanover Regional Medical Center (NHRMC)
Favorite
10:45 AM – 11:45 AM
(6-022) Evaluation of Antibiotic Therapy and the Impact of Macrolide Treatment on Clinical Outcomes in Patients Hospitalized Due to Pneumococcal Bacteremia
Favorite
10:45 AM – 11:45 AM
(6-023) Comparison Between Medical Waste Strategies for Healthcare Facilities
Favorite
10:45 AM – 11:45 AM
(6-024) Impact of Granulocyte Colony Stimulating Factor (GCSF) on time to neutrophil recovery, graft-versus-host disease, and survival after allogeneic hematopoietic stem-cell transplant
Favorite
10:45 AM – 11:45 AM
(6-025) Expiration Analysis of the International Space Station Pharmacy for Exploration Mission Planning
Favorite
10:45 AM – 11:45 AM
(6-026) Evaluation of prescribing practices for sodium zirconium cyclosilicate for the treatment of hyperkalemia in pediatric patients at an academic medical institution
Favorite
10:45 AM – 11:45 AM
(6-027) Assessment of Risankizumab-rzaa Use in Adult Patients with Moderate to Severe Crohn’s Disease throughout the Duke University Health System (DUHS)
Favorite
10:45 AM – 11:45 AM
(6-028) Simulation of Multi-Gene Pharmacogenomic Testing in Colorectal Cancer Patients Receiving 5-Fluorouracil
Favorite
10:45 AM – 11:45 AM
(6-029) Prospective Evaluation of Patient Perceived Barriers to Adherence to Oral Chemotherapy
Favorite
10:45 AM – 11:45 AM
(6-030) Analysis of Experiential Education Absence Policies for Mental Health Criteria
Favorite
10:45 AM – 11:45 AM
(6-031) Implementation of Standard Infusion Concentrations in Neonates and Infants at a Major Medical Center
Favorite
10:45 AM – 11:45 AM
(6-032) Patient Satisfaction with Pharmacist-Led COPD Inhaler Education Live Video-Based Telehealth Clinic
Favorite
10:45 AM – 11:45 AM
(6-033) Building the rationale for a national immunization registry in the U.S.
Favorite
10:45 AM – 11:45 AM
(6-034) Diabetes Mellitus, Hypertension, and Coronary Artery Disease Outcomes After Clinical Pharmacist Intervention in the Primary Care Setting
Favorite
10:45 AM – 11:45 AM
(6-035) Assessing Institutional Compliance with Antibiotic Guidelines for Non-purulent Skin and Soft Tissue Infections at East Carolina University (ECU) Health System
Favorite
10:45 AM – 11:45 AM
(6-036) Comparison of Fixed-Dose vs. Weight-Based Dosing of 4-Factor Prothrombin Complex Concentrate and Effects on Blood Transfusion Rate
Favorite
10:45 AM – 11:45 AM
(6-037) DOAC Loading Dose versus No Loading Dose for VTE Treatment after Parenteral Anticoagulation
Favorite
10:45 AM – 11:45 AM
(6-038) Evaluation of Institutional Compliance to Antibiotic Therapy and Purulent Skin and Soft Tissue Infection Guidelines
Favorite
10:45 AM – 11:45 AM
(6-039) Evaluating IV Iron Discordance Among Patients within the Cone Health Outpatient Infusion Centers
Favorite
10:45 AM – 11:45 AM
(6-040) Comparative Assessment of Closed System Transfer Devices Using NIOSH’s Vapor Containment Performance Protocol During Pharmacy Compounding and Administration of Hazardous Drugs
Favorite
10:45 AM – 11:45 AM
(6-041) Screening for postpartum depression in patients at a perinatal substance use clinic in Western North Carolina
Favorite
10:45 AM – 11:45 AM
(6-042) Modeling the Economic Burden of Postpartum Hemorrhage Due to Substandard Uterotonics In Ghana
Favorite
10:45 AM – 11:45 AM
(6-043) Evaluating Anticoagulation and Hemostasis Management in a Community Hospital
Favorite
10:45 AM – 11:45 AM
(6-044) Evaluation of Bleeding Events Related to Direct Oral Anticoagulants at a Veteran Affairs Medical Center
Favorite
10:45 AM – 11:45 AM
(6-045) Evaluation of Pharmacist Impact on Hypertension Control in a Family Medicine Practice: A Health Disparity Quality Improvement Interdisciplinary Intervention
Favorite
10:45 AM – 11:45 AM
(6-046) The Role of the Emergency Medicine Pharmacist in Initiation and Timing of Antibiotic Prophylaxis in Trauma Patients with Open Fractures
Favorite
10:45 AM – 11:45 AM
(6-047) Survey of Drug Therapy Following Surgical Intervention in Severe, Fulminant C. difficile Infection
Favorite
10:45 AM – 11:45 AM
(6-048) Review of Non-Traditional Buprenorphine Inductions in a Family Medicine Practice in Western North Carolina
Favorite
10:45 AM – 11:45 AM
(6-050) Evaluation of Adherence to Teclistamab Risk Evaluation and Mitigation Strategies at an Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(6-051) Evaluation of Use and Duration of Therapy of Eculizumab and Ravulizumab in Patients with Atypical Hemolytic Uremic Syndrome
Favorite
10:45 AM – 11:45 AM
(6-052) Evaluation of Full Versus Abbreviated Loading Durations of Apixaban and Rivaroxaban After Initial Parenteral Anticoagulation in the Treatment of Venous Thromboembolism
Favorite
10:45 AM – 11:45 AM
(6-053) Retrospective Analysis of Vancomycin and Fidaxomicin Use for Clostridioides Difficile Infections at The University of North Carolina Medical Center
Favorite
10:45 AM – 11:45 AM
(6-054) Evaluation of Piperacillin/Tazobactam Usage in the Pediatric Intensive Care Unit at ECU Health Maynard Children’s Hospital
Favorite
10:45 AM – 11:45 AM
(6-055) Insulin Overbasalization in Family Medicine Patients
Favorite
10:45 AM – 11:45 AM
(6-056) Retrospective Emergency Department Discharge Antibiotic Prescription Pick-Up Assessment at Atrium Health
Favorite
10:45 AM – 11:45 AM
(6-057) Evaluation of Low-Dose Apixaban Regimens at a Large Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(6-058) Review of Glucagon Prescribing for Patients Presenting to the Emergency Department for Hypoglycemia
Favorite
10:45 AM – 11:45 AM
(6-059) Medication-use Evaluation of IV(Intravenous) Sotalol within an Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(6-060) Review of Student Pharmacist Involvement in Fulfilling Statin use in Persons with Diabetes Quality Metric Within Atrium Health
Favorite
10:45 AM – 11:45 AM
(6-061) Off-Label Use of Concentrated Insulin Lispro U-200 in Type 1 and Type 2 Diabetes
Favorite
10:45 AM – 11:45 AM
(6-062) Assessing the Effectiveness of a Pharmacist-Led Hepatitis C Virus (HCV) Program for Low income, Under- and Uninsured Patients at a Free Clinic
Favorite
10:45 AM – 11:45 AM
(6-063) Evaluation of Inhaler Prescribing Trends in Patients with Unconfirmed Chronic Obstructive Pulmonary Disease (COPD): An Interim Analysis
Favorite
10:45 AM – 11:45 AM
(6-064) Estimating Impact of Oral Linezolid Used for Selected Infections
Favorite
10:45 AM – 11:45 AM
(6-066) Vitamin D Supplementation in Neonates Less Than 30 Weeks Gestational Age
Favorite
10:45 AM – 11:45 AM
(6-067) State Affiliate and Student Pharmacist Led Implementation of the Pharmacy Advancement Initiative Self-Assessment Tool Completion in a Rural State
Favorite
10:45 AM – 11:45 AM
(6-068) Faculty Development Series on Diversity, Equity, and Inclusion: Addressing Racism within Pharmacy Education.
Favorite
10:45 AM – 11:45 AM
(6-069) Paving the Way for Pharmacist billing in North Dakota
Favorite
10:45 AM – 11:45 AM
(6-070) Self-Measured Blood Pressure Monitoring Program: Clinical-Pharmacist Led Blood Pressure Management at a Federally Qualified Health Center
Favorite
10:45 AM – 11:45 AM
(6-071) Glycemic Variability with Once-Daily versus Twice-Daily Insulin Glargine in Critically Ill Patients
Favorite
10:45 AM – 11:45 AM
(6-072) Dare to Discuss: Difficult Opioid Harm Reduction Conversations Made Easier with an Innovative Educational Tool
Favorite
10:45 AM – 11:45 AM
(6-073) Charting the Course: Mapping Independent, Pharmacist-owned Community Pharmacy Services in North Dakota
Favorite
10:45 AM – 11:45 AM
(6-074) Huntington's Disease Drug Development: A Phase 3 Pipeline Analysis
Favorite
10:45 AM – 11:45 AM
(6-075) Quality improvement project to narrow health equity gaps for Veterans with diabetes
Favorite
10:45 AM – 11:45 AM
(6-076) MOTIVE: Pharmacist perceptions of the integration of motivational interviewing-based decision tools to address vaccine hesitancy
Favorite
10:45 AM – 11:45 AM
(6-077) Utilization of Antimicrobial Prophylaxis and Gastroprotection in Neurology Patients Discharged with Immunosuppressive Corticosteroids
Favorite
10:45 AM – 11:45 AM
(6-078) Evaluation of Emergency Department Discharge Antibiotics after a One Time Dose of an Intravenous Antibiotic
Favorite
10:45 AM – 11:45 AM
(6-079) Hydroxyurea Oral Suspension Compounding: Simulation of Time Savings Using an Automated Compounding Device Versus Conventional Compounding Procedures
Favorite
10:45 AM – 11:45 AM
(6-080) Evaluation of a Multiplex PCR Pneumonia Panel on Antimicrobial Stewardship and Length of Stay in a Community Hospital
Favorite
10:45 AM – 11:45 AM
(6-081) Evaluation of posaconazole use in an intensive care unit setting in patients unable to take medications by mouth
Favorite
10:45 AM – 11:45 AM
(6-082) Emergency Contraception Availability in a Nationwide Sample of U.S. Colleges and Universities
Favorite
10:45 AM – 11:45 AM
(6-083) Review of the Transition from Weight-Based Dosing to a Fixed Dose Regimen of Four-Factor Prothrombin Complex Concentrate at a Community Hospital
Favorite
10:45 AM – 11:45 AM
(6-084) Evaluation of Student Pharmacists’ Personal Reflections of a Poverty Simulation
Favorite
10:45 AM – 11:45 AM
(6-085) Formulation and evaluation of beta-cyclodextrin versus hydroxypropyl-beta-cyclodextrin additives to a 1% prednisolone ophthalmic formulation
Favorite
10:45 AM – 11:45 AM
(6-086) Evaluating a Palliative Care Consulting Service: Characterizing Medication Utilization and Deprescribing
Favorite
10:45 AM – 11:45 AM
(6-087) Avoidant/Restrictive Food Intake Disorder (ARFID) in a Patient taking Dulaglutide
Favorite
10:45 AM – 11:45 AM
(6-088) Compounding on Camera: A Content Analysis of Pharmaceutical Compounding-Themed TikTok Videos
Favorite
10:45 AM – 11:45 AM
(6-089) Improving Statin Use in Patients with Diabetes Mellitus in an Internal Medicine Clinic
Favorite
10:45 AM – 11:45 AM
(6-090) Prevalence and Predictors of Non-Benzodiazepine Use in Patients with Alcohol Withdrawal Syndrome in United States Emergency Departments - a cross-sectional study
Favorite
10:45 AM – 11:45 AM
(6-091) Medication Use Evaluation of Citalopram: A Comprehensive Analysis
Favorite
10:45 AM – 11:45 AM
(6-092) Evaluation Of The Therapeutic Potential Role Of Herbal Medicine For SARS-Cov-2: Review Of Literature
Favorite
10:45 AM – 11:45 AM
(6-093) Addressing disparities in patients with history of diabetes not on statin therapy
Favorite
10:45 AM – 11:45 AM
(6-094) Retrospective Evaluation of Medication Dosing in Obesity in a Community Healthcare System
Favorite
10:45 AM – 11:45 AM
(6-095) Examining the Relationship Between Professional Identity and Imposter Phenomenon in 2024 PharmD Candidates
Favorite
10:45 AM – 11:45 AM
(6-096) Trends in novel anticancer agent approvals from 2012 to 2022
Favorite
10:45 AM – 11:45 AM
(6-097) Follow up analysis: Impact of a pharmacy resident ASP on-call program coupled with rapid diagnostic technology on patients with bacteremia secondary to multidrug-resistant pathogens
Favorite
10:45 AM – 11:45 AM
(6-098) Optimization of Electronic Health Record Medication Dose Warnings at an Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(6-099) Incidence of Uncontrolled Hyperglycemia in Patients in the Intensive Care Unit with Acute Respiratory Distress Syndrome Receiving High Dose Dexamethasone
Favorite
10:45 AM – 11:45 AM
(6-100) Evaluation of Azithromycin Usage in the Treatment of Chronic Obstructive Pulmonary Disease and Community-acquired Pneumonia
Favorite
10:45 AM – 11:45 AM
(6-101) Improving Naloxone Use for Opioid Reversal in Hospitalized Cancer Patients
Favorite
10:45 AM – 11:45 AM
(6-102) Treatment Toxicities, Genetic Referrals, and Supportive Care in Young Adult Patients with Gastrointestinal Cancers
Favorite
10:45 AM – 11:45 AM
(6-103) Incidence of Acute Kidney Injury Related to Vancomycin Dosing Interval
Favorite
10:45 AM – 11:45 AM
(6-104) Minimizing Fall Risks: Tracking Inpatient Interventions to Promote Safe Use of Select Potentially Inappropriate Medications in Patients Aged 65 and Above
Favorite
10:45 AM – 11:45 AM
(6-105) Differences in Serum Creatinine and Cystatin-C Based Glomerular Filtration Rate Calculations and Identification of Acute Kidney Injury in the Pediatric Intensive Care Unit
Favorite
10:45 AM – 11:45 AM
(6-106) Creative strategies in providing medication education to caregivers of a pediatric hematopoietic cell transplant patient with limited health literacy.
Favorite
10:45 AM – 11:45 AM
(6-108) Medication Interactions with Nuclear Medicine Procedures: A Medication Safety Project
Favorite
10:45 AM – 11:45 AM
(6-109) Tenecteplase (TNK) versus alteplase (tPA) door to needle time in treatment of acute ischemic stroke
Favorite
10:45 AM – 11:45 AM
(6-110) Pharmacy Students Advancing Mental Health Equity in an Underserved Racial/Ethnic Community
Favorite
10:45 AM – 11:45 AM
(6-111) Assessing Antibiotic Stewardship in Strep Throat Treatment
Favorite
10:45 AM – 11:45 AM
(6-112) Seizure Incidence in Patients Receiving Cefepime, Piperacillin-Tazobactam, or No Antibiotics
Favorite
10:45 AM – 11:45 AM
(6-113) Characterizing Current Prescribing Patterns of Levetiracetam for Seizure Prophylaxis in Patients with Traumatic Brain Injury and Intracranial Hemorrhage.
Favorite
10:45 AM – 11:45 AM
(6-114) Retrospective Evaluation of Anti-Xa Monitoring for Enoxaparin Prophylaxis in Obese Patients
Favorite
10:45 AM – 11:45 AM
(6-115) HIV Medication Use in Pregnancy, are we Following the Guidelines?
Favorite
10:45 AM – 11:45 AM
(6-116) Adherence to Cleveland Clinic Health System Restriction Criteria: Intravenous Immunoglobulin Medication Use Evaluation
Favorite
10:45 AM – 11:45 AM
(6-117) Accuracy of Oral Fluid Opioid and Benzodiazepine Monitoring in Palliative Cancer Patients
Favorite
10:45 AM – 11:45 AM
(6-118) Analysis of Medications Prescribed and Dispensed at Columbus Free Clinic
Favorite
10:45 AM – 11:45 AM
(6-119) Risk Factor Analysis and Incidence of Bradycardia With the Use of Remdesivir for COVID-19
Favorite
10:45 AM – 11:45 AM
(6-120) Evaluation of Concomitant Amiodarone and Posaconazole in Lung Transplant Recipients
Favorite
10:45 AM – 11:45 AM
(6-121) Treatment of Extensive Stage Small Cell Lung Cancer in the Setting of Uncontrolled Chronic Lymphocytic Leukemia
Favorite
10:45 AM – 11:45 AM
(6-122) Assessment of Medication Histories in the Pediatric Population
Favorite
10:45 AM – 11:45 AM
(6-123) Analysis of Payor Response Following Launch of Adalimumab Biosimilar Products at a Pediatric Institution
Favorite
10:45 AM – 11:45 AM
(6-124) Retrospective Evaluation of Diabetic Ketoacidosis Protocol Ordering and Execution Compliance
Favorite
10:45 AM – 11:45 AM
(6-125) Adjusted Versus Total Body Weight for Dosing of Antihemophilic Factor VIII in Overweight and Obese Hemophilia A Patients
Favorite
10:45 AM – 11:45 AM
(6-126) Comparing Clinical Outcomes of Obese Patients with MRSA Bacteremia Treated with Daptomycin 7 mg/kg or Greater using Adjusted vs. Total Body Weight-based Dosing
Favorite
10:45 AM – 11:45 AM
(6-127) Evaluation of an Emergency Department Discharge Prescription Review Process in a Freestanding Children’s Hospital
Favorite
10:45 AM – 11:45 AM
(6-128) Assessing Clinical Outcomes in Obese Patients with Persistent MRSA Bacteremia: Comparative Analysis of Daptomycin Dosing Strategies Based on Adjusted vs. Total Body Weight
Favorite
10:45 AM – 11:45 AM
(6-129) Quetiapine in Child and Adolescent Psychiatry
Favorite
10:45 AM – 11:45 AM
(6-130) Impact of Reduced Auto-Verification Usage on Patient Care
Favorite
10:45 AM – 11:45 AM
(6-131) Examining The Underinsured/At-Risk Populations: Impact and Opportunities for Infusion Clinics
Favorite
10:45 AM – 11:45 AM
(6-132) Charting Your Clinical Journey: University of Cincinnati’s Expert Panels for Advanced Pharmacy Practice Experience (APPE) and Residency Readiness
Favorite
10:45 AM – 11:45 AM
(6-133) Evaluation of Quetiapine Prescribing at Discharge after a Diagnosis of Delirium in the Intensive Care Unit
Favorite
10:45 AM – 11:45 AM
(6-134) Evaluation of Empiric Vancomycin Therapy for Neonatal Infectious Workups in Relation to Methicillin-resistant Staphylococcus Aureus (MRSA) Risk Factors
Favorite
10:45 AM – 11:45 AM
(6-135) Gap-Analysis of Pharmacy Compliance with Risk Evaluation and Mitigation Strategy (REMS) Programs in an Inpatient Hospital Pharmacy
Favorite
10:45 AM – 11:45 AM
(6-136) Enhancing Medication Safety of Look Alike Sound Alike Medications within Hospital Carousels
Favorite
10:45 AM – 11:45 AM
(6-137) Evaluating the Utility of Student Written Practice Assessment Questions in a Pharmacy Therapeutics Course
Favorite
10:45 AM – 11:45 AM
(6-138) Risk Factors for Discordant Nasal Methicillin-resistant Staphylococcus Aureus Surveillance Screening Results and Methicillin-resistant Staphylococcus Aureus Pneumonia
Favorite
10:45 AM – 11:45 AM
(6-139) Evaluation of Gentamycin and Neomycin Bladder Irrigation for Reducing Recurrence of Urinary Tract Infection in a Pediatric Institution
Favorite
10:45 AM – 11:45 AM
(6-140) Intravenous Physical Compatibility of Ondansetron Hydrochloride and Nafcillin Sodium
Favorite
10:45 AM – 11:45 AM
(6-141) Desmopressin for Uremic Bleeding Prophylaxis: A Case Report
Favorite
10:45 AM – 11:45 AM
(6-142) Physical Compatibility of Clinically Used Concentrations of Ceftazidime-Avibactam with 0.45% Sodium Chloride and Plasma-Lyte A
Favorite
10:45 AM – 11:45 AM
(6-143) Perception of Stigma Surrounding Mental Health
Favorite
10:45 AM – 11:45 AM
(6-144) Patient Safety in the Era of Compounded Glucagon-Like Peptide-1 Receptor Agonists; An Emergency Department Case of Unintentional Semaglutide Overdose
Favorite
10:45 AM – 11:45 AM
(6-145) Effects of Personal Education on Mental Health Resource Awareness at a Rural Regional College
Favorite
10:45 AM – 11:45 AM
(6-146) Orforglipron: An Investigational Non-Peptide Glucagon-Like Pedtide-1 Receptor Agonist for Oral Treatment of Type 2 Diabetes and Obesity
Favorite
10:45 AM – 11:45 AM
(6-147) Retatrutide for Type 2 Diabetes and Obesity: An Investigational Triple Agonist of Glucagon-Like Peptide-1 (GLP-1), Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon Receptors
Favorite
10:45 AM – 11:45 AM
(6-148) Teplizumab-mzwv for the Delay of Stage 3 Type 1 Diabetes
Favorite
10:45 AM – 11:45 AM
(6-149) Survodutide: An Investigational Glucagon Receptor and Glucagon-Like Peptide-1 Receptor Dual Agonist Injectable Treatment for Type 2 Diabetes and Obesity
Favorite
10:45 AM – 11:45 AM
(6-150) High-Dose Oral Semaglutide for Type 2 Diabetes Management and Weight Loss
Favorite
10:45 AM – 11:45 AM
(6-151) Donislecel: A Novel FDA-Approved Treatment Approach for Complicated Type 1 Diabetes
Favorite
10:45 AM – 11:45 AM
(6-152) Investigational Insulin Icodec: The First Once-Weekly Basal Insulin for the Treatment of Type 1 or Type 2 Diabetes
Favorite
10:45 AM – 11:45 AM
(6-153) Revefenacin administered to an older adult in the intensive care unit: a case report
Favorite
10:45 AM – 11:45 AM
(6-154) Limitations and barriers of continuous glucose monitors in the elderly population
Favorite
10:45 AM – 11:45 AM
(6-155) Vasopressin Induced Hyponatremia in Neonates and Infants 3 months of Age and Under
Favorite
10:45 AM – 11:45 AM
(6-156) Safety and Efficacy of Area-Under-the-Curve versus Trough-Based Vancomycin Dosing Strategies in Patients with Obesity
Favorite
10:45 AM – 11:45 AM
(6-157) Impact of Nursing Delegation Protocol on Order Accuracy for High Dose Influenza Vaccine in Solid Organ Transplant Recipients
Favorite
10:45 AM – 11:45 AM
(6-158) Evaluation of Testosterone Replacement Therapy for Hypogonadism in a Veterans Affairs Health System
Favorite
10:45 AM – 11:45 AM
(6-159) Time Interval Between Treatment Decision and Delivery of Anti-CD20 Therapy for Multiple Sclerosis: A Five-Year, Single Center Experience
Favorite
10:45 AM – 11:45 AM
(6-160) Transitioning Veterans Between Two Formulations of Insulin Glargine U-300 Based on Cost and Safety Standpoints
Favorite
10:45 AM – 11:45 AM
(6-161) Evaluating the Use of Dextrose 50 to Treat Hypoglycemia in the Intensive Care Unit
Favorite
10:45 AM – 11:45 AM
(6-162) Evaluating the Impact of Diarrhea-Inducing Drugs on the Appropriateness of Clostridioides difficile Testing
Favorite
10:45 AM – 11:45 AM
(6-163) Evaluation of Antimicrobial Prescribing for Urinary Tract Infection in the Emergency Department
Favorite
10:45 AM – 11:45 AM
(6-164) The Financial Impact for Medicare Beneficiaries’ Part D Insulin Before and After the Inflation Reduction Act
Favorite
10:45 AM – 11:45 AM
(6-165) Prescribing Patterns of Anti-CD20 Monoclonal Antibodies for Multiple Sclerosis: A Five Year, Single Center Experience
Favorite
10:45 AM – 11:45 AM
(6-166) Evaluation of Intravenous Ketorolac-Associated Nephrotoxicity in Pediatric Patients During Hospital Stay
Favorite
10:45 AM – 11:45 AM
(6-167) Evaluation of tacrolimus prescribing patterns in post-operative heart transplant recipients
Favorite
10:45 AM – 11:45 AM
(6-168) Effectiveness of Legacy Health's pediatric area under the curve vancomycin dosing protocol on reducing vancomycin-associated acute kidney injury
Favorite
10:45 AM – 11:45 AM
(6-169) Status of Population Health & Quality Improvement Pharmacy Practices in Oregon
Favorite
10:45 AM – 11:45 AM
(6-170) Enhancing Patient Safety: Implementation and Assessment of Drug Allergy Interaction Checking for Inactive Ingredients and Dyes in the EPIC System at St. Charles Healthcare
Favorite
10:45 AM – 11:45 AM
(6-171) Retrospective study investigating the incidence of CMV infection and the degree of leukopenia in seronegative liver transplant recipients treated with valganciclovir
Favorite
10:45 AM – 11:45 AM
(6-172) Dalbavancin for the Treatment of Endocarditis
Favorite
10:45 AM – 11:45 AM
(6-173) Impact on HbA1c and Analysis of Interventions in a Pharmacist-Led Diabetes Service within an Endocrinology Clinic
Favorite
10:45 AM – 11:45 AM
(6-174) Gentamicin dosing trends in peripartum mothers with suspected intraamniotic infections in an urban community medical center
Favorite
10:45 AM – 11:45 AM
(6-175) Updating Extemporaneous Chemotherapy Compounding Guidelines and Assessing Alternative Routes of Administration of Oral Oncology Drugs
Favorite
10:45 AM – 11:45 AM
(6-176) Assessment of a clinical pharmacist-run nirmatrelvir/ritonavir prescribing service
Favorite
10:45 AM – 11:45 AM
(6-177) Retrospective review of rash and dermatologic toxicities from combination of allopurinol and bendamustine
Favorite
10:45 AM – 11:45 AM
(6-178) Azathioprine is as Effective as Mycophenolate with a Lower Incidence of Neutropenia in Orthotopic Liver Transplant Recipients
Favorite
10:45 AM – 11:45 AM
(6-179) Evaluation of trends in melatonin and sedative utilization after policy changes in a pediatric Medicaid population
Favorite
10:45 AM – 11:45 AM
(6-180) Peripartum Gentamicin Dosing, a Systematic Review of the Literature on Dosing Weight
Favorite
10:45 AM – 11:45 AM
(6-181) Impact of Drug Shortage on Medication Choice for Therapy of Attention Deficit Hyperactivity Disorder
Favorite
10:45 AM – 11:45 AM
(6-182) Assessing the Impact of Polyamines on Leishmania Donovani Parasites through Fluorescence Microscopy
Favorite
10:45 AM – 11:45 AM
(6-183) Investigating the Conotoxin MIIIB as a Treatment for Multiple Sclerosis Using an In Silico Approach
Favorite
10:45 AM – 11:45 AM
(6-184) Association Between Serum Vitamin B12 Concentration and Obesity Among Adults in Saudi Arabia
Favorite
10:45 AM – 11:45 AM
(6-185) The Development of an LC-MS/MS Screening Assay for Conotoxins in Mouse Synaptosomes; An Application to the Conotoxin MIIIB
Favorite
10:45 AM – 11:45 AM
(6-186) Investigating the Effect of Polyamine Starvation on the Metabolism of Leishmania Parasites
Favorite
10:45 AM – 11:45 AM
(6-187) In Silico Targeting of Voltage-Gated Calcium Channels from Leishmania with ω-Conotoxins
Favorite
10:45 AM – 11:45 AM
(6-188) Retrospective Cost Analysis of Proposed Dose Rounding for Acetaminophen, Ibuprofen, and Ceftriaxone Utilization in a Children's Hospital Emergency Department
Favorite
10:45 AM – 11:45 AM
(6-189) Outcomes of an Initiative to Address Barriers to Semaglutide for Diabetes Usage at a Federally Qualified Health Center
Favorite
10:45 AM – 11:45 AM
(6-190) Deferasirox as supportive therapy for patients with mild to moderate-risk myelodysplastic syndromes
Favorite
10:45 AM – 11:45 AM
(6-191) Evaluation of Doxycycline in the Emergency Department
Favorite
10:45 AM – 11:45 AM
(6-192) Prevalence of Medications That Increase Risk of Falls and Bleeding in Older Adults in Oregon
Favorite
10:45 AM – 11:45 AM
(6-193) Missing dose occurrences within a VA healthcare system: a comprehensive assessment towards effective interventions
Favorite
10:45 AM – 11:45 AM
(6-194) Evaluation of Pharmacy-Managed Warfarin Collaborative Drug Therapy Agreement
Favorite
10:45 AM – 11:45 AM
(6-195) Evaluation of Taxane Infusion Reaction Management
Favorite
10:45 AM – 11:45 AM
(6-196) Formulary Drug Utilization Evaluation to Identify Potential Cost Savings at a Community Hospital
Favorite
10:45 AM – 11:45 AM
(6-197) Food and Drug Administration's (FDA) Application of the One Health Approach: a Focus on Pharmacy
Favorite
10:45 AM – 11:45 AM
(6-198) Evaluation of gentamicin dosing strategies in peripartum patients
Favorite
10:45 AM – 11:45 AM
(6-199) Nutritional Literacy Among Healthcare Professionals
Favorite
10:45 AM – 11:45 AM
(6-200) Comparing Door-to-Needle Times with or without the presence of an ED Pharmacist
Favorite
10:45 AM – 11:45 AM
(6-201) Mitigation of Doxorubicin-Induced Cardiotoxicity by Phytochemicals in Micelles
Favorite
10:45 AM – 11:45 AM
(6-202) Assessing Intravenous Ketamine Utilization and Safety Across a Health System
Favorite
10:45 AM – 11:45 AM
(6-203) Are providers targeting appropriate cholesterol goals for secondary ASCVD prevention in patients who also have diabetes?
Favorite
10:45 AM – 11:45 AM
(6-204) Revisiting the Methylphenidate Exposure Guideline: Pennsylvania Poison Center Experience
Favorite
10:45 AM – 11:45 AM
(6-205) Evaluation of Fixed Dose 4F-PCC Reversal for Warfarin
Favorite
10:45 AM – 11:45 AM
(6-206) Comparison of Heparin Infusion Time-In-Range with Pharmacist Intervention Versus without Pharmacist Intervention
Favorite
10:45 AM – 11:45 AM
(6-207) Presentation, Treatment, and Clinical Outcomes of Patients with Lyme Carditis: A Descriptive Study
Favorite
10:45 AM – 11:45 AM
(6-208) Prospective Feedback and Audit: A Targeted Intervention on Antibiotic Prescribing
Favorite
10:45 AM – 11:45 AM
(6-209) Evaluation of Clinical Outcomes and Serotonin Syndrome in Patients Receiving Linezolid and Serotonergic Agents at an Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(6-210) Effects of Pneumococcal Urine Antigen Testing on Antibiotic Selection in A Community Hospital
Favorite
10:45 AM – 11:45 AM
(6-211) Exploring the Potential Efficacy of Medical Cannabis for Major Depressive Disorder: A Hypothesis-Generating Study
Favorite
10:45 AM – 11:45 AM
(6-212) Assessment of pharmacy students enrolled in the pediatric elective at an institution and their confidence in treating pediatric populations prior to Advanced Professional Practice Experiences
Favorite
10:45 AM – 11:45 AM
(6-213) Perceptions of a University Community on Individuals with Active Substance Use and Individuals in Recovery
Favorite
10:45 AM – 11:45 AM
(6-214) Assessing the Perceptions, Attitudes, Beliefs, Patterns and Practice of Primary Care Providers Regarding Medical Marijuana as They Communicate to Older Adults.
Favorite
10:45 AM – 11:45 AM
(6-215) Retrospective Review of the Impact of Antipsychotics for the Treatment of Pediatric Intensive Care Unit Associated Delirium
Favorite
10:45 AM – 11:45 AM
(6-216) Sodium-Glucose Cotransporter-2 Inhibitor Initiation in Patients Hospitalized for Heart Failure
Favorite
10:45 AM – 11:45 AM
(6-217) Impact of Central or Peripheral Vascular Access Device on Infectious and Mechanical Complications in Adult Hospitalized Patients Receiving Parenteral Nutrition
Favorite
10:45 AM – 11:45 AM
(6-218) Retrospective review of the impact of implementation of an inpatient rotavirus vaccine policy on immunization rate in a Level IV NICU
Favorite
10:45 AM – 11:45 AM
(6-219) Methadone Guideline Compliance for QTc Monitoring in Patients Receiving Methadone
Favorite
10:45 AM – 11:45 AM
(6-220) Developing a School of Pharmacy Dashboard to Integrate Continuing Education Activities with Pharmacy Student Education
Favorite
10:45 AM – 11:45 AM
(6-221) Sex Differences in the Effectiveness of Ketamine Treatment on LPS-Induced Depressive Behaviors: A Preliminary Study
Favorite
10:45 AM – 11:45 AM
(6-222) Weight Loss Medication Outcomes Across BMI Classifications in Primary Care
Favorite
10:45 AM – 11:45 AM
(6-223) Cost Effective Analysis of Pembrolizumab vs Placebo as Adjuvant Therapy in Resected Stage IIb/IIc Melanoma
Favorite
10:45 AM – 11:45 AM
(6-224) Impact of Vasoactive Medication Administration at Initiation of Parenteral Nutrition on Subsequent Metabolic Outcomes in Critically Ill Patients
Favorite
10:45 AM – 11:45 AM
(6-225) Impact of Vasoactive Medication Administration at Initiation of Parenteral Nutrition on Total Duration of Parenteral Nutrition in Critically Ill Patients
Favorite
10:45 AM – 11:45 AM
(6-226) Overdoses Involving GLP-1 Receptor Agonists Reported to Two Regional Poison Control Centers
Favorite
10:45 AM – 11:45 AM
(6-227) Impact of the Number of Vascular Access Device Lumens on Infectious and Mechanical Complications for Adult Hospitalized Patients Receiving Parenteral Nutrition
Favorite
10:45 AM – 11:45 AM
(6-228) Dose optimization of glucagon-like peptide-1 agonists in primary care
Favorite
10:45 AM – 11:45 AM
(6-229) Beers medication utilization and deprescribing in older adults with a history of fall
Favorite
10:45 AM – 11:45 AM
(6-230) Impact of guided weight-based medication dosing in obese pediatric patients
Favorite
10:45 AM – 11:45 AM
(6-231) Suspected Colchicine Toxicity at Therapeutic Doses
Favorite
10:45 AM – 11:45 AM
(6-232) Vitamin D Deficiency and Transplantation and Cellular Therapy
Favorite
10:45 AM – 11:45 AM
(6-233) Developing a Fluorescent Method to Measure Early Doxorubicin Nuclear Uptake in Triple Negative Breast Cancer Cells
Favorite
10:45 AM – 11:45 AM
(6-234) Case of Amebic Liver Abscess and Treatment Considerations
Favorite
10:45 AM – 11:45 AM
(6-236) Utilizing Lenalidomide Suspension as an Effective Therapeutic Alternative for a Dysphagic Multiple Myeloma Patient
Favorite
10:45 AM – 11:45 AM
(6-237) Pharmaceutical Industry Overview for Pharmacy Students and Faculty Advisors
Favorite
10:45 AM – 11:45 AM
(6-238) Determining Patient Preferences Of Switching From An Oral To Long Acting Injectable Antipsychotic Within The Community Pharmacy Setting
Favorite
10:45 AM – 11:45 AM
(6-239) Hyperammonemia with Valproic Acid: A Case Report
Favorite
10:45 AM – 11:45 AM
(6-240) Methotrexate-Induced Toxicity: A Case Report
Favorite
10:45 AM – 11:45 AM
(6-241) Combinations of fentanyl with veterinary anesthetic xylazine produce unique antinociceptive effects depending on the dose ratios in mice
Favorite
10:45 AM – 11:45 AM
(6-242) Fournier’s Gangrene with Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor Empagliflozin: Case Report
Favorite
10:45 AM – 11:45 AM
(6-243) Nitrofurantoin Induced Interstitial Pneumonitis: A Case Report
Favorite
10:45 AM – 11:45 AM
(6-244) Assessing the Clinical Outcomes of Outpatients with Type 2 Diabetes Whose Care is Being Managed by Ambulatory Pharmacists
Favorite
10:45 AM – 11:45 AM
(6-245) Evaluation of Disease State Topics Taught in a Doctor of Pharmacy Curriculum Using the ACCP Toolkit
Favorite
10:45 AM – 11:45 AM
(6-246) Utility of Medicaid Expansion for Health Outcomes in Female Breast Cancer Patients: Scoping Review
Favorite
10:45 AM – 11:45 AM
(6-247) Evaluation of misoprostol and dinoprostone drug utilization review in labor induction
Favorite
10:45 AM – 11:45 AM
(6-248) Empowering Pharmacy Interns Through Personalized Mentorship: A Successful Prescription for Career Growth
Favorite
10:45 AM – 11:45 AM
(6-249) Development and implementation of a student pharmacist-led opioid disposal patient outreach program
Favorite
10:45 AM – 11:45 AM
(6-250) Assessment of Medication Use and Dosing in Living Donor Liver Transplant Donors
Favorite
10:45 AM – 11:45 AM
(6-251) Using rabbit Anti-Thymocyte Globulin for Chronic Lung Allograft Dysfunction: impacts on lung function, survival, and infection
Favorite
10:45 AM – 11:45 AM
(6-252) Evaluating Delirium Outcomes and the Role of Precipitating Medications in Older Adults Throughout Transitions of Care
Favorite
10:45 AM – 11:45 AM
(6-253) Over-the-Counter Medication and Supplement Utilization in Older Adults with Mental Health Concerns
Favorite
10:45 AM – 11:45 AM
(6-254) Implementation of a Behavioral Goal Assessment Tool for Pharmacist-led Diabetes Education Encounters
Favorite
10:45 AM – 11:45 AM
(6-255) Association between everolimus time-in-therapeutic range and change in renal function in lung transplant recipients
Favorite
10:45 AM – 11:45 AM
(6-256) Triptan Medication Utilization in a Psychiatric Inpatient Setting
Favorite
10:45 AM – 11:45 AM
(6-257) Development of an Over-the-Counter Hormonal Contraceptive Learning Module for Second-Year Student Pharmacists
Favorite
10:45 AM – 11:45 AM
(6-258) Association of Everolimus Time in Therapeutic Range on Progression of Chronic Lung Allograft Dysfunction in Lung Transplant Patients
Favorite
10:45 AM – 11:45 AM
(6-259) Reviewing Compliance of a Pharmacist-Driven De-escalation Protocol for Proton Pump Inhibitor to Histamine-2 Receptor Antagonist in the Inpatient Setting.
Favorite
10:45 AM – 11:45 AM
(6-260) Safety Outcomes Associated with Rate-Controlling Medications to Manage Atrial Fibrillation in Patients with Heart Failure
Favorite
10:45 AM – 11:45 AM
(6-261) Outcomes Associated with Rate Control Strategies in Patients with Atrial Fibrillation and Heart Failure
Favorite
10:45 AM – 11:45 AM
(6-262) Pilot Palliative Care Pharmacist-led Opioid Deprescribing Clinic: Feasibility, Safety, and Efficacy
Favorite
10:45 AM – 11:45 AM
(6-263) Visual Representation of Social Determinants of Health through Photovoice
Favorite
10:45 AM – 11:45 AM
(6-264) Assessing the impact of industry-related experiences during pharmacy school on interest in pursuing opportunities in industry
Favorite
10:45 AM – 11:45 AM
(6-265) Retrospective Analysis of a Pharmacist 48-hour Stop Protocol on Intravenous (IV) Hydromorphone Use in Hospitalized Patients
Favorite
10:45 AM – 11:45 AM
(6-266) Increasing access to appropriate emergency contraception at the Shadyside Family Health Center
Favorite
10:45 AM – 11:45 AM
(6-267) Hypoglycemia Quality Improvement
Favorite
10:45 AM – 11:45 AM
(6-268) Enhancing Professional Identity Formation (PIF) in Pharmacy Students through an Innovative Advanced Pharmacy Practice Experience (APPE) Rotation
Favorite
10:45 AM – 11:45 AM
(6-269) Rehabilitation Patient Perceptions of a COVID-19 Booster Vaccination for the Fall of 2023
Favorite
10:45 AM – 11:45 AM
(6-270) Duration of Antibiotic Prescriptions Upon Discharge from Emergency Observation
Favorite
10:45 AM – 11:45 AM
(6-271) Analysis of Acid Suppression Prescribing Practices in Patients with Clostridium Difficile Infections
Favorite
10:45 AM – 11:45 AM
(6-272) Barriers to Wellness Activities and Interest in Wellness Services among Uninsured Adults Utilizing the Volunteers in Medicine Health Clinic
Favorite
10:45 AM – 11:45 AM
(6-273) Analysis of the mRNA Therapeutic Landscape: the Developing Scope of Targeted Drugs
Favorite
10:45 AM – 11:45 AM
(6-274) Evaluating Amoxicillin Prescriptions for Dental Indications in a Free Primary Care Clinic
Favorite
10:45 AM – 11:45 AM
(6-275) Assessing Appropriate Dual Antiplatelet Therapy (DAPT) Usage Among Participants in the Program of All-Inclusive Care for the Elderly (PACE-RI) of Rhode Island
Favorite
10:45 AM – 11:45 AM
(6-276) Safety of Dose-Reduced Pemetrexed in Patients with Renal Impairment
Favorite
10:45 AM – 11:45 AM
(6-277) Assessing the Effect of Antimicrobial Stewardship Education on Antibiotic Prescribing Patterns in Asymptomatic bacteriuria
Favorite
10:45 AM – 11:45 AM
(6-278) Assessing Menopause in the Modern Day: A Survey of American and South Korean Women
Favorite
10:45 AM – 11:45 AM
(6-279) Systematic Review and Meta-Analysis of the Safety and Efficacy of Intranasal Esketamine for Treatment Resistant Depression in Active Suicidal Ideation with Intent
Favorite
10:45 AM – 11:45 AM
(6-280) Chemoprevention of Colorectal Cancer Using Garlic Dietary Supplements: A Systematic Review
Favorite
10:45 AM – 11:45 AM
(6-281) Do Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Differ in Their Effects on the Risk of Dementia in Systematic Reviews/Meta-Analyses of Hypertension Randomized Controlled Trials?
Favorite
10:45 AM – 11:45 AM
(6-282) Evaluation of Naloxone Keychain Utilization for Destigmatizing and Assessing the Carrying Frequencies of Intranasal Naloxone
Favorite
10:45 AM – 11:45 AM
(6-283) Geriatric Malnutrition Serum Biomarker Evaluation: Beyond Body Mass Index
Favorite
10:45 AM – 11:45 AM
(6-284) Evaluating Dalbavancin Use at a Tertiary Medical Center
Favorite
10:45 AM – 11:45 AM
(6-285) Contraceptive Use and Trends Among Female Students at the University of Rhode Island
Favorite
10:45 AM – 11:45 AM
(6-286) Evaluation of Modified Intravenous Thiamine Dosing and Administration for Prevention and Treatment of Wernicke’s Encephalopathy
Favorite
10:45 AM – 11:45 AM
(6-287) Medication Use Evaluation of a Twice Daily Metronidazole Dosing Strategy for Anaerobic Infections at a Tertiary Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(6-288) National Survey of the General Public’s Perceptions of Community Pharmacists as Dementia Care Navigators
Favorite
10:45 AM – 11:45 AM
(6-289) Impact of Barcode Scanning Restock Technology on Pharmacy Technician Labor
Favorite
10:45 AM – 11:45 AM
(6-290) Discrepancies in Hydroxyurea Ordering Between Adult and Pediatric Patients at an Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(6-291) Pharmacist-led Interdisciplinary Cardiovascular Risk Reduction for People Living with HIV: A Prospective Quality Improvement Cohort Intervention
Favorite
10:45 AM – 11:45 AM
(6-292) Evaluating the effectiveness of fludrocortisone and hypertonic saline for hyponatremia in subarachnoid hemorrhage patients
Favorite
10:45 AM – 11:45 AM
(6-293) Evaluating the Appropriateness of Vitamin K (phytonadione) Usage for Reversing an Elevated International Normalized Ratio Secondary to Warfarin Therapy
Favorite
10:45 AM – 11:45 AM
(6-294) Assessing the Safety of Gabapentin in Older Adults with Multiple Comorbidities at a Program of All-Inclusive Care for the Elderly
Favorite
10:45 AM – 11:45 AM
(6-295) Quality Improvement Review of Diabetes Control Among Patients Co-Managed By an Embedded Clinical Pharmacist
Favorite
10:45 AM – 11:45 AM
(6-296) What Organisms are Isolated in Breast Surgical Site Infections?
Favorite
10:45 AM – 11:45 AM
(6-297) Failure Was Not An Option: Implementation of Multidisciplinary Approach to Inpatient Heart Failure Education for Discharge
Favorite
10:45 AM – 11:45 AM
(6-298) Evaluation of the Relationship Between Malnourishment, Obesity, and Alcohol Use Disorder in the Acute Care Setting
Favorite
10:45 AM – 11:45 AM
(6-299) The Role of Digoxin in New-Onset Atrial Fibrillation in Critically Ill Patients with Septic Shock
Favorite
10:45 AM – 11:45 AM
(6-300) Staphylococcus Aureus Biofilm Viability After Daptomycin or Vancomycin in Combination with an Anti-EPS Agent
Favorite
10:45 AM – 11:45 AM
(6-301) Systematic Review of Dietary Supplements for Hair Growth
Favorite
10:45 AM – 11:45 AM
(6-302) Evaluating the Effectiveness of Infographics on Students’ Patient Counseling Skills and Confidence
Favorite
10:45 AM – 11:45 AM
(6-303) National Health and Nutrition Examination Survey Data Analysis: Estimated Glomerular Filtration Rate and Chronic Kidney Disease Staging in Insulin-Dependent versus Insulin-Naïve Individuals with Diabetes
Favorite
10:45 AM – 11:45 AM
(6-304) Incidence of Treatment-Emergent Adverse Events in Women with Moderate to Severe Postpartum Depression with Brexanolone Compared to Placebo: A Meta Analysis
Favorite
10:45 AM – 11:45 AM
(6-305) Assessment of Antithrombotic Stability in Patients with a Percutaneous Left Ventricular Support Device and Sodium Bicarbonate Purge
Favorite
10:45 AM – 11:45 AM
(6-306) Assessment of 4-Factor Prothrombin Complex Concentrate Utilization in Cardiac Surgery Patients
Favorite
10:45 AM – 11:45 AM
(6-307) Medication Use Evaluation of 4-Factor Prothrombin Complex Concentrate Within a Large Academic Healthcare System
Favorite
10:45 AM – 11:45 AM
(6-308) Assessing the Pharmaceutical-Care Needs of People Living with Parkinson’s Disease Through the EMPOWER PD Clinics - An Interdisciplinary Model of Care that Integrates Pharmacy Services.
Favorite
10:45 AM – 11:45 AM
(6-309) Evaluating the Impact of Educational Interventions on Smart Infusion Pump Interoperability Compliance at Lawrence + Memorial Hospital
Favorite
10:45 AM – 11:45 AM
(6-310) Evaluation of Phenobarbital Loading Dose Strategies Associated with Treatment Failure in Alcohol Withdrawal Syndrome
Favorite
10:45 AM – 11:45 AM
(6-312) Evaluating the Effect of ACE-I/ARBs on Overall Survival in NSCLC Patients: A Systematic Review and Meta-Analysis
Favorite
10:45 AM – 11:45 AM
(6-313) Dragon Bite: Treatment of a Mangrove Monitor Wound
Favorite
10:45 AM – 11:45 AM
(6-314) Evaluation of Heparin Infusion Utilization and Variability in Patient Response
Favorite
10:45 AM – 11:45 AM
(6-315) Reasoning for Declining to Prescribe Naloxone at an Academic Medical Center After the Implementation of Electronic Health Record Prompts in Response to New State Law
Favorite
10:45 AM – 11:45 AM
(6-316) Investigating Standards for Integration of Pharmacogenomics into Electronic Health Records: Advancing Quality Precision Medicine for Personalized Patient Care
Favorite
10:45 AM – 11:45 AM
(6-317) Comparison of the Impact of a System Tele-Antimicrobial Stewardship Program on the Conversion of Intravenous-to-Oral Antimicrobials in Multiple Regional Health Networks
Favorite
10:45 AM – 11:45 AM
(6-318) Assessment of Practitioner Knowledge and Therapeutic Approaches for Reducing Stroke Risk in Patients with Nonvalvular Atrial Fibrillation
Favorite
10:45 AM – 11:45 AM
(6-319) Medication-Use Evaluation of Intravenous Acetylcysteine Based on Formulary Restrictions at a Large Multi-Hospital Health System
Favorite
10:45 AM – 11:45 AM
(6-320) Annual Wholesale Acquisition Costs of Novel Drugs Relative to United States County Level Housing Prices
Favorite
10:45 AM – 11:45 AM
(6-321) Evaluation of factors associated with uncontrolled hypertension in a Medicare Accountable Care Organization (ACO) population
Favorite
10:45 AM – 11:45 AM
(6-322) Exploring Quality Standards for Promoting Health Equity in Digital Therapeutics
Favorite
10:45 AM – 11:45 AM
(6-323) Evaluation of Ceftaroline Fosamil Use at an Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(6-324) Medication Use Evaluation (MUE) of Cefdinir in the Emergency Department (ED)
Favorite
10:45 AM – 11:45 AM
(6-325) Assessment of Weight Loss and Adverse Effects with Phentermine/Topiramate in Left Ventricular Assistance Device Patients
Favorite
10:45 AM – 11:45 AM
(6-326) Evaluation of Belatacept Use in Kidney Transplant Recipients
Favorite
10:45 AM – 11:45 AM
(6-327) Use of Intrapleural Alteplase in the Treatment of Parapneumonic Effusion in Children: A Report of a 10-year Experience
Favorite
10:45 AM – 11:45 AM
(6-328) Prolonged impact of meropenem exposure on valproic acid serum levels: a case report
Favorite
10:45 AM – 11:45 AM
(6-329) Appropriateness of Use and Fixed Dosing as Compared to Weight-Based Dosing with 4-Factor Prothrombin Complex Concentrate
Favorite
10:45 AM – 11:45 AM
(6-330) Creation of a Longitudinal Advanced Pharmacy Practice Experience (LAPPE) Program at an Academic Medical Center
Favorite
10:45 AM – 11:45 AM
(6-331) Comparative Cost-Effectiveness Analysis of Sotagliflozin versus Empagliflozin, Dapagliflozin, Canagliflozin, and Standard of Care in Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease
Favorite
10:45 AM – 11:45 AM
(6-332) Diabetic Retinopathy Associations with Antidiabetic Agents: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
Favorite
10:45 AM – 11:45 AM
(6-333) Online Promotion of Resident Research and Research Training Among Postgraduate Year 2 (PGY2) Emergency Medicine Pharmacy Residency Programs
Favorite
10:45 AM – 11:45 AM
(6-334) Opioid Prescribing by Emergency Medicine Physicians: Trends Study of Medicare Part D Prescriber Data 2013–2019
Favorite
10:45 AM – 11:45 AM
(6-335) Rhabdomyolysis Associations with Statins: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
Favorite
10:45 AM – 11:45 AM
(6-336) Hemorrhagic Stroke Associations with Statins: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
Favorite
10:45 AM – 11:45 AM
(6-337) Association of Altmetric Attention Scores with Citations of Pharmacist Authors in Selected Major Emergency Medicine Journals
Favorite
10:45 AM – 11:45 AM
(6-338) Cyclin-dependent Mediator Kinases CDK8/19 Are Essential for Transcriptional Reprogramming That Leads to Resistance to Lapatinib Treatment in HER2-positive Breast Cancer
Favorite
10:45 AM – 11:45 AM
(6-339) A Cross-Sectional Survey Investigating Pharmacists’ Perceived Confidence of Knowledge on Human Immunodeficiency Injectable Pre-Exposure Prophylaxis Guidelines Compared to Actual Knowledge
Favorite
10:45 AM – 11:45 AM
(6-340) Assessment of Pre-exposure Prophylaxis (PrEP) Uptake Among Qualifying Patients in Three Southeastern Hospitals
Favorite
10:45 AM – 11:45 AM
(6-341) Guideline-Directed Utilization of Sodium-Glucose Cotransporter-2 Inhibitors within the Clinical Setting
Favorite
10:45 AM – 11:45 AM
(6-342) Addressing Antimicrobial Resistance with the Development of a Statewide Antibiogram in South Carolina
Favorite
10:45 AM – 11:45 AM
(6-343) Experience with Ceftaroline Fosamil in Children: A Medication Use Evaluation with a Focus on Clinical Outcomes
Favorite
10:45 AM – 11:45 AM
(6-344) The Impact of Participation in a Structured Early Assurance Program on Pharmacy Student Leadership Engagement
Favorite
10:45 AM – 11:45 AM
(6-345) Evaluating Risk Factors: Unveiling Clinical Risks in Potentially Contaminated Compounded Medications
Favorite
10:45 AM – 11:45 AM
(6-346) Seizure Associations with Neuromuscular Blocking Agents: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
Favorite
10:45 AM – 11:45 AM
(6-347) Assessment of Oxaliplatin Infusion Reactions Before and After Vaccination with Coronavirus Disease 2019 (COVID-19) mRNA Vaccine
Favorite
10:45 AM – 11:45 AM
(6-349) Implementation of an Empyema Management Order Set: Compliance Before and After
Favorite
10:45 AM – 11:45 AM
(6-350) Successful use of Micafungin in a Patient with Confirmed Caspofungin Hypersensitivity
Favorite
10:45 AM – 11:45 AM
(6-351) Real-World Evidence of Opioid-Related Adverse Drug Interactions: A Systematic Review
Favorite
10:45 AM – 11:45 AM
(6-352) What are Private Pharmacy Practice Faculty Publishing?; Characterizing Peer-Reviewed Publications at Private Colleges and Schools of Pharmacy in the United States
Favorite
10:45 AM – 11:45 AM
(6-353) Quality Improvement: Student Pharmacist-Facilitated Implementation of Opioid Stewardship Practices for Patients on Chronic Opioid Therapy in a Rural Family Medicine Clinic
Favorite
10:45 AM – 11:45 AM
(6-354) Examining Extrapyramidal Side Effects in CYP2D6 Poor Versus Normal Metabolizers Receiving Metoclopramide
Favorite
10:45 AM – 11:45 AM
(6-355) Evaluation of Clostridium Difficile Treatment in Pediatrics
Favorite
10:45 AM – 11:45 AM
(6-356) Evaluation of Antimicrobial Stewardship for Urinary Tract Infections After Pharmacist-Led Provider Education
Favorite
12:00 PM – 1:00 PM
Student Posters
12:00 PM – 1:00 PM
(7-001) Feasibility of Finerenone Initiation in an Uninsured Patient Population
Favorite
12:00 PM – 1:00 PM
(7-002) Evaluation of stability of omeprazole oral suspension using forced degradation technique
Favorite
12:00 PM – 1:00 PM
(7-003) Utilization Uptake of GLP-1 Receptor Agonists for Weight Loss
Favorite
12:00 PM – 1:00 PM
(7-004) Tennessee Dataset: A Correlation Between Smoking, Depression, and Overall Physical Health
Favorite
12:00 PM – 1:00 PM
(7-005) Evaluation of Lithium Utilization at an Inpatient Mental Health Facility to Optimize Patient Outcomes
Favorite
12:00 PM – 1:00 PM
(7-006) Assessing the Impact of Clinical Pharmacy Services in a Residential Women’s Substance Use Facility
Favorite
12:00 PM – 1:00 PM
(7-007) Appropriateness of second dose antibiotics in Emergency Department patients with sepsis and septic shock based on presenting location
Favorite
12:00 PM – 1:00 PM
(7-008) Proteomic Profiling of Exosome Preparations Identify the Antiproliferative Effects of Celecoxib in Colorectal Cancer Cells
Favorite
12:00 PM – 1:00 PM
(7-009) Unveiling the hidden cost of poverty: Hypertension
Favorite
12:00 PM – 1:00 PM
(7-010) Stability of Lorazepam Oral Solution Repackaged in Plastic Oral Syringes at Room and Refrigerated Temperatures
Favorite
12:00 PM – 1:00 PM
(7-011) Development of a Skin Patch of Baclofen for Sustained Management of Multiple Sclerosis Associated Spasticity
Favorite
12:00 PM – 1:00 PM
(7-012) Impact of Guideline Changes on the Management of Non-Critically Ill Adults Admitted to the Hospital with Community-Acquired Pneumonia
Favorite
12:00 PM – 1:00 PM
(7-013) 90-day Stability Investigation of Individually Repackaged Prasugrel Tablets
Favorite
12:00 PM – 1:00 PM
(7-014) Cost Evaluation of Piperacillin/Tazobactam IV Preparation Formulary Changes
Favorite
12:00 PM – 1:00 PM
(7-015) Impact of Insurance Status on Initiation of anti-Tumor Necrosis Factor Alpha Biologic Therapy in Children with Juvenile Idiopathic Arthritis
Favorite
12:00 PM – 1:00 PM
(7-016) Evaluating and Refining Risk in Drug Diversion Prevention Software: Insights from a Community Hospital
Favorite
12:00 PM – 1:00 PM
(7-017) Extended Antibiotic Prophylaxis Following Total Joint Replacement At A Large Tertiary Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(7-018) Evaluation of Vancomycin for Complicated Intraabdominal Infections (IAI)
Favorite
12:00 PM – 1:00 PM
(7-019) Barriers to Growth Hormone Access in Patients at an Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(7-020) Advancement of Enteral Nutrition in Critically Ill Patients with Traumatic Spinal Cord Injury Receiving Phenylephrine
Favorite
12:00 PM – 1:00 PM
(7-021) Annual Analysis of Quarterly Severe Hypoglycemic Events at a Large Tertiary Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(7-022) Evaluation of Mindset and Attitudes Towards Interprofessional Education Among Health Science Programs at Lipscomb University
Favorite
12:00 PM – 1:00 PM
(7-023) Effect of liraglutide and semaglutide on fibronectin ED-A assembly in idiopathic pulmonary fibrosis (IPF) lung fibroblasts.
Favorite
12:00 PM – 1:00 PM
(7-024) Functional effect of liraglutide and semaglutide on myofibroblasts using collagen contraction assay: implications in Idiopathic Pulmonary Fibrosis
Favorite
12:00 PM – 1:00 PM
(7-025) Evaluating Effectiveness of Antidote Reporting at Capturing Adverse Drug Reactions (ADRs)
Favorite
12:00 PM – 1:00 PM
(7-026) Reducing Vancomycin-Associated Acute Kidney Injury through area under the curve/minimum inhibitory concentration dosing: A Two-Year Follow-Up Proof of Concept Study
Favorite
12:00 PM – 1:00 PM
(7-027) Impact of Hospitalization on Continuation of SGLT-2 Inhibitors for Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease, or Heart Failure in Type 2 Diabetes Mellitus Patients
Favorite
12:00 PM – 1:00 PM
(7-028) Impact of Hospitalization on Continuation of GLP-1 Agonists for Atherosclerotic Cardiovascular Disease in Type 2 Diabetes Mellitus Patients
Favorite
12:00 PM – 1:00 PM
(7-029) Predictive Value of MRSA Nasal PCR Testing on Microbial Culture Results
Favorite
12:00 PM – 1:00 PM
(7-030) Projected Impact of CYP 2C19 Pharmacogenomic Information on Commonly Prescribed Medications
Favorite
12:00 PM – 1:00 PM
(7-031) Comparing Antibiotic Administration Methods in Sepsis: IV Push vs. IV Piggyback and Their Impact on Treatment Times and Bundle Compliance
Favorite
12:00 PM – 1:00 PM
(7-032) Evaluation of Linezolid Associated Thrombocytopenia, Hypertension, and Serotonin Syndrome
Favorite
12:00 PM – 1:00 PM
(7-033) Evaluating the Impact of Clinical Pharmacists in Facilitating Access to Diabetes Medications using Medication Assistance Programs for Underinsured and Uninsured Patients
Favorite
12:00 PM – 1:00 PM
(7-034) Assessment of Bone-Targeting Agents in Eligible Patients at Baptist Cancer Center – A Drug Use Evaluation
Favorite
12:00 PM – 1:00 PM
(7-035) Assessing Student Pharmacists’ Self-Reported Confidence in Recalling Schedules of Commonly Dispensed Controlled Substances
Favorite
12:00 PM – 1:00 PM
(7-036) Employing insulin trigger tool methodology to detect and evaluate hypoglycemia adverse drug events in the acute-care setting
Favorite
12:00 PM – 1:00 PM
(7-037) Utilizing the ISMP Guidelines for Sterile Compounding and the Safe Use of Sterile Compounding Technology as a gap-analysis tool across a health-system
Favorite
12:00 PM – 1:00 PM
(7-038) Assessing the Impact of Social Determinants of Health on Medication Safety Practices
Favorite
12:00 PM – 1:00 PM
(7-039) Eculizumab Usage in the Treatment of Transplant-Associated Thrombotic Microangiopathy at St. Jude Children’s Research Hospital
Favorite
12:00 PM – 1:00 PM
(7-040) Validation and Characterization of F. nucleatum FabK as A Narrow Spectrum Antibacterial Target for Colorectal Cancer
Favorite
12:00 PM – 1:00 PM
(7-041) Assessing Pharmacists’ Techniques and Self-Reported Confidence in Maintaining Competency in Pharmacy Law
Favorite
12:00 PM – 1:00 PM
(7-042) Ustekinumab for Inflammatory Bowel Disease: Dose Escalations in an Integrated Health System Specialty Pharmacy
Favorite
12:00 PM – 1:00 PM
(7-043) Pharmacist Interventions on Management of Adverse Events from Oral Chronic Lymphocytic Leukemia Treatment
Favorite
12:00 PM – 1:00 PM
(7-044) Safety of High-Dose Deutetrabenazine in Huntington’s Disease Chorea: A Multi-Site Study
Favorite
12:00 PM – 1:00 PM
(7-045) Single-Center Evaluation of Outcomes Associated with Implementation of Electronic Health Record Sterile Compounding Technology on Hazardous Drug Preparations
Favorite
12:00 PM – 1:00 PM
(7-046) Artificial Intelligence-Powered Patient Education: Bridging Healthcare Knowledge Gaps? Assessing Accuracy and Comprehension of AI-Generated Patient Education Materials.
Favorite
12:00 PM – 1:00 PM
(7-047) Impact of Remdesivir on INR in Patients Receiving Chronic Warfarin Therapy
Favorite
12:00 PM – 1:00 PM
(7-048) Application of recurring revenue business metrics to the membership pharmacy model
Favorite
12:00 PM – 1:00 PM
(7-049) Discovering the Factors Affecting Frequency and Confidence in Medication Counseling and Lifestyle Modifications Provided from Community Pharmacists in Rural Versus Urban Areas in Puerto Rico
Favorite
12:00 PM – 1:00 PM
(7-050) Automated Dispensing Cabinet Optimization to Reduce Medication Stock-Out Rates
Favorite
12:00 PM – 1:00 PM
(7-051) Implementation of Short-Course Cefixime Prophylaxis for Irinotecan-Induced Diarrhea Reduces Antibiotic Exposure in Pediatric Oncology Patients
Favorite
12:00 PM – 1:00 PM
(7-052) Systematic Review of Levetiracetam versus Phenytoin for Seizure Prophylaxis in Traumatic Brain Injury
Favorite
12:00 PM – 1:00 PM
(7-053) Knowledge, Attitudes, and Prevalence of Cannabidiol (CBD) Use Among College Students Enrolled at Academic Institutions within The University of Texas System
Favorite
12:00 PM – 1:00 PM
(7-054) Assessing Optimal Utilization of Benztropine for Extrapyramidal Symptoms within Behavioral Health
Favorite
12:00 PM – 1:00 PM
(7-055) Evaluation of Safety Outcome of Alteplase for Acute Massive Pulmonary Embolism
Favorite
12:00 PM – 1:00 PM
(7-056) Determining the Relationship and Impact of Student-Faculty Ratio on Pharmacy Student Success
Favorite
12:00 PM – 1:00 PM
(7-057) Oral Iron with Vitamin C Supplementation to Reduce Need for Blood Transfusions in Acute Trauma
Favorite
12:00 PM – 1:00 PM
(7-058) Beta-Lactam Allergy Documentation and Prophylactic Antibiotic Appropriateness in Cesarean Section
Favorite
12:00 PM – 1:00 PM
(7-059) A Survey to Assess Pharmacy Student Knowledge Regarding Pediatric Pharmacotherapy and Weight-Based Dosing
Favorite
12:00 PM – 1:00 PM
(7-060) Evaluation of Antithrombin III Utilization in a Free-Standing Pediatric Hospital
Favorite
12:00 PM – 1:00 PM
(7-061) Evaluation of Appropriate use of Amiodarone for Atrial Fibrillation Prophylaxis in Post Coronary Artery Bypass Graft (CABG) Surgery Patients
Favorite
12:00 PM – 1:00 PM
(7-062) Management of Atrial Fibrillation with Rapid Ventricular Response Using Digoxin: A Systematic Review
Favorite
12:00 PM – 1:00 PM
(7-063) Prevalence in the use of medications for Attention Deficit/ Hyperactivity Disorder, anxiety and depression in Texas Pharmacy Schools
Favorite
12:00 PM – 1:00 PM
(7-064) A Systematic Review of Phenobarbital Versus Benzodiazepines in Alcohol Withdrawal Syndrome
Favorite
12:00 PM – 1:00 PM
(7-065) Cannabis-Induced Priapism in a Healthy Adult Male
Favorite
12:00 PM – 1:00 PM
(7-066) Clinical and Economic Impact of Comprehensive Genomic Profiling (CGP) in Cancer Treatment
Favorite
12:00 PM – 1:00 PM
(7-067) Kidney Health Discussions During Clinical Encounters with Acute Kidney Injury Survivors: a Videographic Analysis
Favorite
12:00 PM – 1:00 PM
(7-068) Augmented Renal Clearance in trauma patients and the use of Enoxaparin
Favorite
12:00 PM – 1:00 PM
(7-069) Evaluating Safety and Efficacy of Zolpidem Use in Spaceflight
Favorite
12:00 PM – 1:00 PM
(7-070) A Case of Fluoxetine Induced Severe Post-Operative Bleeding Evaluated By Pharmacogenomics Testing
Favorite
12:00 PM – 1:00 PM
(7-071) Evaluating the Cumulative and Countervailing Interplay of Chronic Conditions and Related Medications on Dementia Risk
Favorite
12:00 PM – 1:00 PM
(7-072) Development and Characterization of a Nano-emulsion Formulation of GMC1
Favorite
12:00 PM – 1:00 PM
(7-073) Impact of Pharmacy Automation Business Intelligence Dashboard on Medication Waste Reduction and Optimized Allocation at an Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(7-074) Early Initiation of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) and Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Kidney Transplant Recipients
Favorite
12:00 PM – 1:00 PM
(7-075) Evaluating the drug choice and cognitive behavioral interventions for weight loss: significance of understanding the related mechanisms of action and adverse event pathophysiology
Favorite
12:00 PM – 1:00 PM
(7-076) Tacrolimus Safety in a Non-Transplant Community Hospital Abstract
Favorite
12:00 PM – 1:00 PM
(7-078) Assessing the Appropriate Use and Compliance with the Restriction Criteria for Leuprolide Acetate in a County Health System
Favorite
12:00 PM – 1:00 PM
(7-079) Effects of Scheduled Acetaminophen and Gabapentin in Opioid Use for Patients Undergoing Coronary Artery Bypass Graft Surgery
Favorite
12:00 PM – 1:00 PM
(7-080) Effects of Sodium Polystyrene Sulfonate versus Patiromer in the Treatment of Acute Hyperkalemia
Favorite
12:00 PM – 1:00 PM
(7-081) Effects of Hydrogen Sulfide-Releasing Compounds on Pro-Inflammatory Mediators in the Anterior Uvea
Favorite
12:00 PM – 1:00 PM
(7-082) Tracking Fluoroquinolone Use in a Small Community Hospital
Favorite
12:00 PM – 1:00 PM
(7-083) Repurposing FDA-Approved Antiviral Agents: Non-Covalent Inhibitors of SARS-CoV-2 Main Protease and RNA-dependent RNA polymerase Enzymes
Favorite
12:00 PM – 1:00 PM
(7-084) Evaluation and Effectiveness of Glucagon-Like Peptide-1 (GLP-1) Therapies and the Conversion to Dual Incretin Therapy With Glucose-Dependent Insulinotropic Polypeptide/ Glucagon-Like Peptide-1 (GIP/ GLP-1)
Favorite
12:00 PM – 1:00 PM
(7-085) Adult Neurogenesis and Neuronal Restructuring Related to Chronic Environmental Stress Factors
Favorite
12:00 PM – 1:00 PM
(7-086) Outcomes of Screening Long-term Care Facility Residents for QT-prolonging Medications and ECG Monitoring
Favorite
12:00 PM – 1:00 PM
(7-087) Medication Adherence Based on A1c Trends in Diabetic Patients on a Patient Assistance Program
Favorite
12:00 PM – 1:00 PM
(7-088) Control of Chemotherapy-Induced Nausea and Vomiting (CINV) During Hematopoietic Stem Cell Transplant (HSCT) with Traditional Doublet or Triplet Antiemetic Prophylaxis in the Era of Olanzapine
Favorite
12:00 PM – 1:00 PM
(7-089) Narcotic Delivery Verification Pilot at Cook Children's Medical Center
Favorite
12:00 PM – 1:00 PM
(7-090) Hydroxocobalamin Effects on Vasopressor Requirements and Hemodynamics in Vasodilatory Shock
Favorite
12:00 PM – 1:00 PM
(7-091) Evaluating Incidence and Impact of Medication-Related Adverse Events Contributing to Hospital Readmissions in Solid Organ Transplant Patients
Favorite
12:00 PM – 1:00 PM
(7-092) Assessing antibiotic use after the implementation of a sepsis guideline in the neonatal intensive care unit
Favorite
12:00 PM – 1:00 PM
(7-093) Evaluating the Effectiveness of Influenza Vaccine Administration in Preventing Future Pediatric Emergency Department Visits and Hospitalizations Related to Influenza
Favorite
12:00 PM – 1:00 PM
(7-094) Evaluation of Anti-Xa Levels with Treatment Dose Enoxaparin in Variable Patient Populations
Favorite
12:00 PM – 1:00 PM
(7-095) Evaluation of the Student Engagement and Leadership Development Utilizing a Pop Culture-Themed Student Leadership Retreat
Favorite
12:00 PM – 1:00 PM
(7-096) Impact of Hydrocortisone Prophylaxis in the First Seven Days of Life on Bronchopulmonary Dysplasia
Favorite
12:00 PM – 1:00 PM
(7-097) Equipping Pharmacists with the Tools Needed to Provide Pharmacogenomic Information to Patients with Direct-to-Consumer Genetic Test Results
Favorite
12:00 PM – 1:00 PM
(7-098) Medication Utilization Evaluation of Heparin in Total Parenteral Nutrition for Pediatric Patients
Favorite
12:00 PM – 1:00 PM
(7-099) Medication use evaluation of Bivalirudin and Unfractionated Heparin in Pediatric Intensive Care Units
Favorite
12:00 PM – 1:00 PM
(7-100) Evaluation of an Antiretroviral Stewardship Program at a Community Hospital
Favorite
12:00 PM – 1:00 PM
(7-101) Development of an acute care pharmacy clinical quality dashboard
Favorite
12:00 PM – 1:00 PM
(7-102) Effect of Choose-Your-Own-Adventure (CYOA) Activities on Pharmacy Student Knowledge and Critical Thinking
Favorite
12:00 PM – 1:00 PM
(7-103) Investigation of Frailty-associated Health Outcomes Among a National Cohort of Veterans with and without Clostridioides difficile Infection
Favorite
12:00 PM – 1:00 PM
(7-104) Associations Between Frailty and Clostridioides difficile Infection in a National Cohort of Veterans
Favorite
12:00 PM – 1:00 PM
(7-105) Bringing Industry to Texas: A Summarization of The University of Texas at Austin - Industry Pharmacists Organization (IPhO) Efforts to Expand Student Opportunities
Favorite
12:00 PM – 1:00 PM
(7-106) Impact of Pharmacy Student Involvement in Medication Counseling for New Start Anticoagulants on Patient Outcomes and Healthcare Utilization
Favorite
12:00 PM – 1:00 PM
(7-107) Assessment of Barriers to Naloxone Dispensing in an Academic Medical Center Emergency Department
Favorite
12:00 PM – 1:00 PM
(7-108) Impact of Insulin Interchange: Rate of Hypoglycemia Following Inpatient Interchange from Insulin Degludec to Insulin Detemir
Favorite
12:00 PM – 1:00 PM
(7-109) Prevalence of Social Isolation and Associated Coping Skills Among Fourth-Year Pharmacy Students in Advanced Pharmacy Practice Experience Rotations
Favorite
12:00 PM – 1:00 PM
(7-110) Assessment of Adherence to Current Albumin Use Criteria within a Multi-hospital Network
Favorite
12:00 PM – 1:00 PM
(7-111) Medication Use Evaluation of Intravenous Immunoglobulin within a Multi-Hospital Network
Favorite
12:00 PM – 1:00 PM
(7-112) Antibiotic Prescribing Patterns for Urinary Tract Infections (UTIs) at Baylor Scott and White Medical Center – Temple
Favorite
12:00 PM – 1:00 PM
(7-113) Evaluation of the Clinical Impacts of a Specialty Clinical Pharmacist on Time-to-Therapy in the Ambulatory Outpatient Dermatology Clinic
Favorite
12:00 PM – 1:00 PM
(7-114) Perceptions of Transgender and Gender-Diverse Healthcare among Diverse Health Professions Students
Favorite
12:00 PM – 1:00 PM
(7-115) Evaluation of Rationale for Non-Administration of Rotavirus Vaccine in Neonates
Favorite
12:00 PM – 1:00 PM
(7-116) Kratom-Related Information Provided by Smoke Shop Employees: A Cross-Sectional Secret Shopper Study
Favorite
12:00 PM – 1:00 PM
(7-117) Tetrahydrocannabinol (THC)-Related Information Provided by Smoke Shop Employees: A Cross-Sectional Secret Shopper Study
Favorite
12:00 PM – 1:00 PM
(7-118) Evaluation of Dexmedetomidine Dosing for Sedation in Critically Ill Obese Patients
Favorite
12:00 PM – 1:00 PM
(7-119) Assessing the effect of an LGBTQ+ health elective on Doctor of Pharmacy student attitudes, self-perceptions, and stigma at a Hispanic Serving Institution
Favorite
12:00 PM – 1:00 PM
(7-120) Incidence of Potassium Replacement in Patients Admitted Through the Emergency Department with Moderate to Severe Hypokalemia
Favorite
12:00 PM – 1:00 PM
(7-121) Examining Disparities in Healthcare Utilization for Patients with Opioid Use Disorder: A 2016-2019 Analysis by Race and Region in United States Hospitals.
Favorite
12:00 PM – 1:00 PM
(7-122) Characterization of Knowledge, Perceptions, and Stigma Surrounding Transgender and Gender-Diverse Health: A Comparison of Health Professions Students at a Hispanic Serving Institution
Favorite
12:00 PM – 1:00 PM
(7-123) Characterization of Complementary, Alternative and Integrative Medicine (CAIM) Use Among the LGBTQIA+ Population in a United States-Mexico Border Community
Favorite
12:00 PM – 1:00 PM
(7-124) Unlocking the Potential: Systematic Review of Corticosteroid Therapy in Community-Acquired Pneumonia
Favorite
12:00 PM – 1:00 PM
(7-125) Grit and Resilience as Predictors for Academic Success in Pharmacy School: A Systematic Review
Favorite
12:00 PM – 1:00 PM
(7-126) Glucagon-like Peptide-1 Receptor Agonist Therapy in a Patient with Type 2 Diabetes with an Intragastric Balloon for Weight Loss
Favorite
12:00 PM – 1:00 PM
(7-127) Improving Appropriate Utilization of Formulary Respiratory Agents for Veterans with Non-VA Healthcare Providers
Favorite
12:00 PM – 1:00 PM
(7-129) Midodrine for Intravenous Vasopressor Weaning
Favorite
12:00 PM – 1:00 PM
(7-130) Utilization of P2Y12 Reaction Unit Testing with P2Y12 Antiplatelet Therapy in Patients at an Academic Tertiary Hospital
Favorite
12:00 PM – 1:00 PM
(7-131) Descriptive Analysis of Inpatient Sodium Glucose Co-Transporter 2 Inhibitor Use
Favorite
12:00 PM – 1:00 PM
(7-132) Impact of prior proton pump inhibitors exposure on C. difficile infection recurrence rates
Favorite
12:00 PM – 1:00 PM
(7-133) Dapagliflozin in acute decompensated heart failure patients with reduced ejection fraction versus mildly reduced or preserved ejection fraction
Favorite
12:00 PM – 1:00 PM
(7-134) Nonadherence to Oral Endocrine Therapy in Underserved Patients with Breast Cancer
Favorite
12:00 PM – 1:00 PM
(7-135) Evaluating the Impact of a Pharmacist-Led Virtual Hypertension Clinic on Blood Pressure Control Compared to Standard Care
Favorite
12:00 PM – 1:00 PM
(7-136) Early versus Late Initiation of New-Start Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) with Acute Decompensated Heart Failure and its Impact on Inpatient Length of Stay
Favorite
12:00 PM – 1:00 PM
(7-137) Evaluation of Empagliflozin in Patients with Heart Failure after Hospital Discharge
Favorite
12:00 PM – 1:00 PM
(7-138) Evaluation of tofersen for the treatment of amyotrophic lateral sclerosis (ALS) in adults with superoxide dismutase 1 (SOD 1) mutation for formulary addition
Favorite
12:00 PM – 1:00 PM
(7-139) Evaluating the Use of Eravacycline in Patients Admitted to an Acute Care Community Hospital
Favorite
12:00 PM – 1:00 PM
(7-140) Evaluation of the clinical impact of rapid diagnostic testing with BioFire FilmArray Blood Culture Identification 2 Panel on antimicrobial stewardship interventions
Favorite
12:00 PM – 1:00 PM
(7-141) Evaluation of Prior Antibiotic Use in Patients with Antibiotic-Associated Diarrhea
Favorite
12:00 PM – 1:00 PM
(7-142) Evaluation of pharmacy to dose vancomycin protocol via AUC/MIC and incidence of acute kidney injury
Favorite
12:00 PM – 1:00 PM
(7-143) Assessing Oral Endocrine Therapy Adherence in Breast Cancer Patients in DHR Health Serving Predominantly Hispanic Patients in the Rio Grande Valley
Favorite
12:00 PM – 1:00 PM
(7-144) A Systematic Review of the Safety of Milrinone in Patients with Heart Failure and Stage 4 or 5 Chronic Kidney Disease
Favorite
12:00 PM – 1:00 PM
(7-145) Therapeutic Duplication Assessment of Incretin Hormones for Diabetes at a Federally Qualified Health Center Pharmacy
Favorite
12:00 PM – 1:00 PM
(7-146) Evaluation of a Diabetic Ketoacidosis Order Set at a Large Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(7-147) Effect of a Pharmacy Research Seminar on Research Confidence Among Pharmacy Residents
Favorite
12:00 PM – 1:00 PM
(7-148) Evaluation of the Appropriateness of Antimicrobials Prescribed at Hospital Discharge in Pediatric Patients
Favorite
12:00 PM – 1:00 PM
(7-149) Blood pressure management in pregnancy: a single center evaluation
Favorite
12:00 PM – 1:00 PM
(7-150) Pharmacist Intervention to Improve Statin Therapy in Persons with Cardiovascular Disease (SPC) and Statin Use in Persons with Diabetes (SUPD)
Favorite
12:00 PM – 1:00 PM
(7-151) Hispanic Obesity Phenotypes: Comparison of Microbiome Signatures Related to Diet and Occupational Physical Activity
Favorite
12:00 PM – 1:00 PM
(7-152) Evaluation of Midostaurin initiation delays for patients with newly diagnosed fms-like tyrosine kinase 3 (FLT3) mutated acute myeloid leukemia (AML)
Favorite
12:00 PM – 1:00 PM
(7-153) Assessing Duplicate Prescribing of DPP-4 Inhibitors and GLP-1 Agonists, a Medication Use Evaluation
Favorite
12:00 PM – 1:00 PM
(7-154) Evaluation of the Timeliness of Venetoclax Administration on Prognostic Outcomes in Patients with Acute Myeloid Leukemia at an Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(7-155) The Evaluation and Comparison of Glucagon-Like-Peptide 1 and Glucose-Dependent Insulinotropic Polypeptide Agonists in Patients with Type 2 Diabetes in an Ambulatory Care Setting
Favorite
12:00 PM – 1:00 PM
(7-156) Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Impact on the Microbiome: Systematic Review
Favorite
12:00 PM – 1:00 PM
(7-157) Hemoglobin A1C (HbA1c) Reduction with a Pharmacist - Run Continuous Glucose Monitoring (CGM) Service in a Federally Qualified Health Center (FQHC)
Favorite
12:00 PM – 1:00 PM
(7-158) Clinical Evaluation of Direct-Acting Oral Anticoagulant Use in Patients at a County Hospital System
Favorite
12:00 PM – 1:00 PM
(7-159) Analyzing the Time to Therapeutic Heparin Levels Utilizing an Institution Specific Low Dose Heparin Protocol in Obese Patients
Favorite
12:00 PM – 1:00 PM
(7-160) Assessment and Optimization of Neonatal Sepsis Intravenous Antibiotic Turnaround Time at an Academic Teaching Hospital
Favorite
12:00 PM – 1:00 PM
(7-161) Evaluation of Mycobacterium Tuberculosis Reactivation in Solid-Organ Transplant Recipients Treated for Latent Tuberculosis Infection
Favorite
12:00 PM – 1:00 PM
(7-162) Evaluating the Impact of Bayesian Software for AUC-Guided Vancomycin Dosing in a Community Hospital
Favorite
12:00 PM – 1:00 PM
(7-163) Evaluation of Sugammadex Utilization After Implementation of Ready to Administer Intravenous (IV) Syringes
Favorite
12:00 PM – 1:00 PM
(7-164) Evaluating the safety and efficacy of patiromer in the management of acute hyperkalemia
Favorite
12:00 PM – 1:00 PM
(7-165) Transition from Levetiracetam to Valproic Acid or Divalproex Sodium in Traumatic Brain Injury Patients: An Exploration of Behavioral Symptoms and Adverse Effects
Favorite
12:00 PM – 1:00 PM
(7-166) Utility of Xpert Carba-R Test in the Management of Carbapenem-Resistant Organism (CRO) Bacteremia
Favorite
12:00 PM – 1:00 PM
(7-167) Antibiotic Selection Compliance in Surgical Patients
Favorite
12:00 PM – 1:00 PM
(7-168) Assessment of Rifaximin Use in Adult Hospitalized Patients at Two Community Hospitals.
Favorite
12:00 PM – 1:00 PM
(7-169) COVID-19: Race and Ethnicity Influence on Type 2 Diabetes
Favorite
12:00 PM – 1:00 PM
(7-170) SEEDing the Path to Pharmacy Student Excellence: Integration of Students in the Planting of a Co-Curricular Skill Development Program
Favorite
12:00 PM – 1:00 PM
(7-171) Type II Diabetes Mellitus and COVID-19: A Case Series Exploring Insulin Management in Patients from Two Family Medicine Clinics
Favorite
12:00 PM – 1:00 PM
(7-172) Breaking Down the Pharmacy Barriers in Chronic Care Management: A Journey of Implementation and Integration
Favorite
12:00 PM – 1:00 PM
(7-173) OnPro Use In The Pediatric Population
Favorite
12:00 PM – 1:00 PM
(7-174) Associations of Social Determinants of Health (SDoH), Perceptions of Health Equity with Colorectal Cancer (CRC) Screening Among Underserved Populations - Qualitative Phase
Favorite
12:00 PM – 1:00 PM
(7-175) WellnessRx: The Prescription for Pharmacy Residency Program Success
Favorite
12:00 PM – 1:00 PM
(7-176) Angiotensin Converting Enzyme Inhibitor Washout Period Prior to Angiotensin Receptor Neprilysin Inhibitor Initiation in the Inpatient Setting
Favorite
12:00 PM – 1:00 PM
(7-177) Assessing the safety and efficacy of enoxaparin and unfractionated heparin dosing regimens for venous thromboembolism prophylaxis in hospitalized morbidly obese patients: a systematic review
Favorite
12:00 PM – 1:00 PM
(7-178) Collaboration among Community Pharmacists and Primary Care Physicians: Strategies in Improving Patient Safety
Favorite
12:00 PM – 1:00 PM
(7-179) Improving Outcomes: Team-Based CCM for Dual-Eligible Patients with Diabetes
Favorite
12:00 PM – 1:00 PM
(7-180) Would’ve, Could’ve, Should’ve: Evaluation of guideline-directed medical therapy prescribing behavior in chronic heart failure upon discharge from a hospital readmission
Favorite
12:00 PM – 1:00 PM
(7-181) Evaluation of Calcitonin Dosing Strategies in Severe Hypercalcemia
Favorite
12:00 PM – 1:00 PM
(7-182) Time is Brain: Impact of Nursing-Driven Alteplase Preparation at Bedside to Reduce Door-to-Needle Times in Acute Ischemic Stroke Management
Favorite
12:00 PM – 1:00 PM
(7-183) Comparison of h-index in Google Scholar and Scopus for translational science trainees
Favorite
12:00 PM – 1:00 PM
(7-184) Identifying the gap in anticoagulation in Medicare Shared Savings Program patients with atrial fibrillation and stroke
Favorite
12:00 PM – 1:00 PM
(7-185) Five Love Language Activities Impact on Quality of Life and Relationship Satisfaction among Cancer Patients Couples Support Groups
Favorite
12:00 PM – 1:00 PM
(7-186) Impact of Scheduled Dialysis on Patient Outcomes at a Federally Qualified Health Center
Favorite
12:00 PM – 1:00 PM
(7-187) Refine Mayo Clinic Pharmacy Residency Recruitment Approach
Favorite
12:00 PM – 1:00 PM
(7-188) Delayed and very delayed gastrointestinal immune-related adverse events with immune checkpoint inhibitors for United States Veterans Affairs patients
Favorite
12:00 PM – 1:00 PM
(7-189) Evaluating the Efficacy and Safety of Sodium Zirconium Cyclosilicate in the Management of Acute Hyperkalemia
Favorite
12:00 PM – 1:00 PM
(7-190) A Dose of Reality: CGM Simulation in the Pharmacy Classroom Learning
Favorite
12:00 PM – 1:00 PM
(7-191) Impact of Internal Medicine Pharmacy Learners on Patient Care and Cost Avoidance in a Large Academic Teaching Hospital
Favorite
12:00 PM – 1:00 PM
(7-192) Nursing Perspectives on Medication Reconciliation: A Comparison Between Inpatient Units and the Emergency Department
Favorite
12:00 PM – 1:00 PM
(7-193) (eQuIP) Quality Improvement Project to Review 2022 ADA Guideline Uptake: Provider Prescribing Patterns for SGLT-2I’s and GLP-1’s in an Academic Clinic.
Favorite
12:00 PM – 1:00 PM
(7-194) Peer-Led Case-Based Learning Strengthens Drug and Disease Knowledge
Favorite
12:00 PM – 1:00 PM
(7-195) Peer-Led Journal Club Strengthens Students' Critical Appraisal Skills Through Engagement and Introspection in Evidence-Based Medicine Evaluation
Favorite
12:00 PM – 1:00 PM
(7-196) First-Year Pharmacy Students Perceived Cultural Competence Knowledge Pre and Post Didactic and Experiential Experiences Utilizing the SAPLCC Questionnaire at a Single Academic Institution
Favorite
12:00 PM – 1:00 PM
(7-197) Knowledge, Attitudes, and Willingness to Pay for Over-the-Counter (OTC) Naloxone: A Nationwide Cross-Sectional Survey
Favorite
12:00 PM – 1:00 PM
(7-198) A case of acute Cryoglobulinemia vasculitis flare after rituximab-abbs infusion
Favorite
12:00 PM – 1:00 PM
(7-199) Unusual Cause of Dry Cough and Shortness of Breath Tricked Admission Team
Favorite
12:00 PM – 1:00 PM
(7-200) Conventional vs Deep Magnetic Stimulation in the Treatment of Major Depressive Disorder
Favorite
12:00 PM – 1:00 PM
(7-201) Evaluation of the Length of Stay Between Single-Dose Intravenous Oritavancin and the Standard Treatment of Vancomycin: A Literature Review
Favorite
12:00 PM – 1:00 PM
(7-202) Use of Fentanyl with Substance Use Disorder Patients and Medication Use Evaluation of Substance Use Disorder Treatments
Favorite
12:00 PM – 1:00 PM
(7-203) Analgesic Response of Salvianolic Acids Towards Neuronal Cells
Favorite
12:00 PM – 1:00 PM
(7-205) Clinical and Economic Impact of Circulating Tumor Deoxyribonucleic Acid (ctDNA) in Cancer Treatment
Favorite
12:00 PM – 1:00 PM
(7-206) Evaluation of Cefiderocol Use and Outcomes at a Small Community Hospital
Favorite
12:00 PM – 1:00 PM
(7-207) Unique Neonatal Intensive Care Unit Dietetic Technician Position for Pharmacy Students
Favorite
12:00 PM – 1:00 PM
(7-208) Loop Diuretics Battling Transfusion-Associated Circulatory Overload (TACO)
Favorite
12:00 PM – 1:00 PM
(7-209) Statin or no Statin: Evaluation of Statin Utilization in a Geriatric Primary Care Practice
Favorite
12:00 PM – 1:00 PM
(7-210) Enhancing Opioid Stewardship at a Community Hospital: Building a Comprehensive Metrics Dashboard
Favorite
12:00 PM – 1:00 PM
(7-211) Mycobacterium Abscessus Treated with a Unique Antimicrobial Regimen Containing the Novel Antibiotic Clofazimine
Favorite
12:00 PM – 1:00 PM
(7-212) Evaluation of Direct Oral Anticoagulants Dosing for Treatment of Left Ventricular Thrombus
Favorite
12:00 PM – 1:00 PM
(7-213) Evaluation of Maximum Weight-Based Dosing Initiation Rate for Low Dose Heparin Protocol in Obesity
Favorite
12:00 PM – 1:00 PM
(7-214) Safety and Efficacy of Early Use of Glucagon-Like Peptide-1 Receptor Agonists After Kidney Transplantation
Favorite
12:00 PM – 1:00 PM
(7-215) Shake It Off: Evaluation of Medications Used for Opioid Withdrawal Syndrome on the Behavioral Health Unit at a Community Hospital
Favorite
12:00 PM – 1:00 PM
(7-216) Polymicrobial bacteremia treated with unique antimicrobial regimen due to social barriers: A long road to recovery
Favorite
12:00 PM – 1:00 PM
(7-217) Assessment of Texas Pharmacist’s Self-Perceived Knowledge of Psychiatric Pharmacotherapy
Favorite
12:00 PM – 1:00 PM
(7-218) Psychedelics for Pharmaceutical Use - What the literature says 2018-2023
Favorite
12:00 PM – 1:00 PM
(7-219) Evaluation of Weight Trends in Prostate Cancer Patients on Anti-Androgen Therapy
Favorite
12:00 PM – 1:00 PM
(7-220) Serdexmethylphenidate/dexmethylphenidate – A Safe and Potentially Promising Therapeutic Option for Childhood Attention Deficit Hyperactivity Disorder
Favorite
12:00 PM – 1:00 PM
(7-221) Evaluation of Digital Therapeutics as Prescribed Therapies and the Pharmacist’s Role
Favorite
12:00 PM – 1:00 PM
(7-222) Evaluation of Intermountain Health Outpatient Infusion Reactions
Favorite
12:00 PM – 1:00 PM
(7-223) The pharmaceutical use of MDMA for the treatment of PTSD
Favorite
12:00 PM – 1:00 PM
(7-224) Intrathecal Drug Delivery System Pocket Injections Reported to a Regional Poison Control Center
Favorite
12:00 PM – 1:00 PM
(7-225) A Community Pharmacy-based Survey on Determining the Status of and Barriers to Providing Birth Control, Emergency Contraception, Naloxone, Immunizations, and Smoking Cessation in Utah
Favorite
12:00 PM – 1:00 PM
(7-226) Rapid Assay for Botulinum Toxin
Favorite
12:00 PM – 1:00 PM
(7-227) Piloting Hospital At Home Pharmacy Services Within An Integrated Health System
Favorite
12:00 PM – 1:00 PM
(7-228) Medication Use Evaluation: Should Gilteritinib Be Added to Inpatient Formulary?
Favorite
12:00 PM – 1:00 PM
(7-229) Medication Use Evaluation: Should Ponatinib be Added to Inpatient Formulary?
Favorite
12:00 PM – 1:00 PM
(7-230) Comparison of Extended Direct Oral Anticoagulant Treatment Strategies for Venous Thromboembolism
Favorite
12:00 PM – 1:00 PM
(7-231) Who Are We Bridging? Description and Outcomes of Anticoagulated Patients Receiving Injectable Bridging Therapy
Favorite
12:00 PM – 1:00 PM
(7-232) Evaluation of Hyponatremia Risk Among Geriatric Patients Exposed to Selective Serotonin Reuptake Inhibitors and Thiazide Diuretics
Favorite
12:00 PM – 1:00 PM
(7-233) Professional Development Curriculum at United States Colleges and Schools of Pharmacy
Favorite
12:00 PM – 1:00 PM
(7-234) Pharmacists’ Satisfaction with Electronic Health Records Software
Favorite
12:00 PM – 1:00 PM
(7-236) Biocreep: How Likely are Noninferiority Trials to Yield Inferior Interventions?
Favorite
12:00 PM – 1:00 PM
(7-237) Impact of Pharmacist Led Quality Improvement Initiative on Statin Adherence in Non-Caucasian or Female Veterans with Diabetes or Cardiovascular Disease
Favorite
12:00 PM – 1:00 PM
(7-238) Sugammadex Appropriateness in the OR at a Critical Care Access Hospital
Favorite
12:00 PM – 1:00 PM
(7-239) Evaluating the Impact of a Modified Neonatal Abstinence Syndrome (NAS) Treatment Protocol: The Eat, Sleep, Console (ESC) Approach in a Level 3 NICU
Favorite
12:00 PM – 1:00 PM
(7-240) Comparison of Hypoxia Inducible Factor-1A (HIF-1A) Polymorphisms between Chronic Kidney Disease patients and healthy subjects
Favorite
12:00 PM – 1:00 PM
(7-241) Effects of an Elective Course of the Tamarkoz(R) Method of Meditation on Self-Awareness and Stress in Doctorate of Pharmacy Students
Favorite
12:00 PM – 1:00 PM
(7-242) Role of CISD1 and CISD2 Genes in Sodium Arsenite-Induced Cytotoxicity and Modulation by Epigallocatechin Gallate in Bronchial Epithelial Cells
Favorite
12:00 PM – 1:00 PM
(7-243) Comprehensive Analysis of Mammography Effectiveness Across Racial Groups
Favorite
12:00 PM – 1:00 PM
(7-244) Comparing CIWA and MINDS in Alcohol Withdrawal Intensive Care Treatment: A Retrospective Cohort Analysis
Favorite
12:00 PM – 1:00 PM
(7-245) Medication Use Evaluation of Amiodarone at a Large Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(7-246) Optimizing Diabetes Care: Impact of a Pharmacist-Led Clinic on Insulin Reduction with Concomitant Use of Incretin Mimetics.
Favorite
12:00 PM – 1:00 PM
(7-247) Prevalence and Risk Factors of Aplastic Anemia in Adult Patients with Gynecologic Malignancies
Favorite
12:00 PM – 1:00 PM
(7-248) Medication Procurement Optimization at UVA Health Children’s (UVAHC) Related to Insurance Mandated Care Steerage in the Ambulatory Setting
Favorite
12:00 PM – 1:00 PM
(7-249) Multidisciplinary Care Plan Approach to Safeguard Against Ocular Toxicity in Gynecologic Malignancies with Antibody Drug-Conjugates
Favorite
12:00 PM – 1:00 PM
(7-250) Impact of Pharmacist-Led Discharge Medication Reconciliation for Behavioral Health Patients
Favorite
12:00 PM – 1:00 PM
(7-251) Thoughts of Potential Leaders: A Descriptive Study About Motivations and Barriers Towards Leadership Among Virginia Pharmacists
Favorite
12:00 PM – 1:00 PM
(7-252) Survey of Health Professional Student Parents Resources and Support
Favorite
12:00 PM – 1:00 PM
(7-253) Evaluation of the Treatment and Eradication of Helicobacter pylori at the International Family Medicine Clinic at the University of Virginia Health
Favorite
12:00 PM – 1:00 PM
(7-254) Efficacy of Fixed-Dose 4-Factor Prothrombin Complex Concentrate Versus INR and Weight Based Dosing for Warfarin Reversal
Favorite
12:00 PM – 1:00 PM
(7-255) Student Pharmacist’s Knowledge, Confidence, and Attitudes About HIV PrEP and PEP Treatments
Favorite
12:00 PM – 1:00 PM
(7-256) Investigation of the effect of spray dryer nozzle size on the particle size distribution of a synthetic surfactant dry powder inhaler formulation.
Favorite
12:00 PM – 1:00 PM
(7-257) Description of School-Based and Student Driven Factors of Pharmacy Schools with the Lowest PGY1 Residency Match Rates from 2019 to 2021
Favorite
12:00 PM – 1:00 PM
(7-258) Medication Use Evaluation (MUE) of Premixed Insulin Analogues Across a Health-System
Favorite
12:00 PM – 1:00 PM
(7-259) Comparison of long-acting subcutaneous injectable preparations of buprenorphine
Favorite
12:00 PM – 1:00 PM
(7-260) Saying Goodbye to PPIs: Deprescribing proton pump inhibitors in patients with cystic fibrosis
Favorite
12:00 PM – 1:00 PM
(7-261) Quality Assurance Practices in Pharmacy Experiential Education: A Scoping Review
Favorite
12:00 PM – 1:00 PM
(7-262) Quantification of the Home Infusion Pharmacist’s Workload through a Review of Pharmacists’ Tasks in an Electronic Health Record (EHR)
Favorite
12:00 PM – 1:00 PM
(7-263) Impact of Pharmacy Students as Lifestyle Coaches on Delivery of National Diabetes Prevention Program
Favorite
12:00 PM – 1:00 PM
(7-264) Health System Specialty Pharmacy Impact on Coordination of Care: A Patient Case
Favorite
12:00 PM – 1:00 PM
(7-265) Classroom Simulation of Medication Reconciliation Using Conversational AI to Enhance Pharmacy Student Knowledge and Confidence
Favorite
12:00 PM – 1:00 PM
(7-266) Impact of Opioid Use Education on Community-Dwelling Older Adults
Favorite
12:00 PM – 1:00 PM
(7-267) Evaluation of Nominal Dose on Four-Factor Prothrombin Complex Concentrate Dosing
Favorite
12:00 PM – 1:00 PM
(7-268) Provider Adherence to the 2022 USPSTF Recommendation on Aspirin for Primary Prevention of Cardiovascular Disease in Older Adults at an Outpatient Geriatric Clinic
Favorite
12:00 PM – 1:00 PM
(7-269) Describing Immunization Education and Training in Schools and Colleges of Pharmacy
Favorite
12:00 PM – 1:00 PM
(7-270) Influencers of Early Career Pharmacy Student Interest in Oncology Pharmacy
Favorite
12:00 PM – 1:00 PM
(7-271) Characterization of Pharmacy Schools with the Top 20 PGY1 Residency Match Rates from 2019 to 2021
Favorite
12:00 PM – 1:00 PM
(7-272) Analysis of Provider Literacy and Prescribing Practices for Insulin Delivery Systems and Compatible Continuous Glucose Monitors
Favorite
12:00 PM – 1:00 PM
(7-273) Evaluating the Relationship between Pharmacy Medication Reconciliation Touchpoints and Potentially Harmful Medication Errors for Patients Discharged to Skilled Nursing Facilities (SNFs)
Favorite
12:00 PM – 1:00 PM
(7-274) Performance of the MAUQ-en-US in a Diverse, Urban Sample of Patients with Chronic Diseases
Favorite
12:00 PM – 1:00 PM
(7-275) Trends in Gender Disparities in Type 2 Diabetes: A Meta-Regression Analysis of Randomized Controlled Trials
Favorite
12:00 PM – 1:00 PM
(7-276) Characterization of Vancomycin Used in the Operating Room
Favorite
12:00 PM – 1:00 PM
(7-277) Comparison of Phenytoin Dose Between Tube Feed and Oral Administration Among Hospitalized Patients
Favorite
12:00 PM – 1:00 PM
(7-278) Quality Assurance Review of Total Parenteral Nutrition (TPN) Collaborative Drug Therapy Agreement Following a Change in Documentation Requirements
Favorite
12:00 PM – 1:00 PM
(7-279) Adherence to Vancomycin Protocols and Attainment of Therapeutic Levels: An Annual Retrospective Audit
Favorite
12:00 PM – 1:00 PM
(7-280) Assessing the Impact of Electronic Health Record Interventions on Optimizing Health Care for Older Adults: A Literature Review
Favorite
12:00 PM – 1:00 PM
(7-281) Artificial Intelligence and Unfolding Cases to Teach Critical Thinking: A Precepting Model
Favorite
12:00 PM – 1:00 PM
(7-282) Trough versus AUC in Vancomycin Monitoring for Clinical and Economical Efficacy
Favorite
12:00 PM – 1:00 PM
(7-283) Initiation of a Pharmacist-Led Continuous Glucose Monitor (CGM) Pro Service in an Outpatient Setting
Favorite
12:00 PM – 1:00 PM
(7-284) Broad Spectrum Antibiotic Use Evaluation in Progressive Care Unit Patients in May and June 2023
Favorite
12:00 PM – 1:00 PM
(7-285) Incidence and Severity of Cytokine Release Syndrome and Neurotoxicity in the Administration of Teclistamab
Favorite
12:00 PM – 1:00 PM
(7-286) Design Thinking in Pharmacy Education: A Framework to Incorporate Stakeholders’ Experiences in Curriculum Adaptations
Favorite
12:00 PM – 1:00 PM
(7-287) Methadone operative and post-operative use: a retrospective evaluation of subsequent opiate medications, and serious adverse events.
Favorite
12:00 PM – 1:00 PM
(7-288) Quality Assurance Auditing on a Warfarin Collaborative Drug Therapy Agreement
Favorite
12:00 PM – 1:00 PM
(7-289) Vancomycin infusion reaction and promotion of inclusive language in an academic medical center
Favorite
12:00 PM – 1:00 PM
(7-290) Audit of Pharmacist Compliance and Success with a Vancomycin and Aminoglycosides Collaborative Practice Agreement (CDTA) at a Community-Based Hospital.
Favorite
12:00 PM – 1:00 PM
(7-291) Voriconazole Therapeutic Drug Monitoring in Adult Burn Patients
Favorite
12:00 PM – 1:00 PM
(7-292) Assessing Inpatient Pharmacists Compliance to the Total Parenteral Nutrition (TPN) Protocol under Collaborative Drug Therapy Agreement (CDTA) in Seattle, Washington.
Favorite
12:00 PM – 1:00 PM
(7-293) Chronic outcomes in a novel mouse model of acute seizure emergencies
Favorite
12:00 PM – 1:00 PM
(7-294) Evaluating the Need for Pharmacy Students During Multidisciplinary Rounds with a Guided Approach
Favorite
12:00 PM – 1:00 PM
(7-295) Secondary analysis of opioid use disorder patients receiving adherence device assisted treatment with Suboxone and the relationship between opioid cravings and illicit opioid use
Favorite
12:00 PM – 1:00 PM
(7-296) Continuous Glucose Monitoring (CGM) and Blood Glucose Monitoring (BGM) Experience: Lessons Learned by Student Pharmacists
Favorite
12:00 PM – 1:00 PM
(7-297) Medication Use Evaluation: Baseline and Routine Monitoring for Veterans Taking Amiodarone at Mann-Grandstaff Veterans Affairs Medical Center
Favorite
12:00 PM – 1:00 PM
(7-298) The pharmacist’s role in a case of allergy labeling and acute bacterial rhinosinusitis treatment
Favorite
12:00 PM – 1:00 PM
(7-299) Inpatient Anticoagulation Services at University of Washington Medical Center Montlake: Annual Audit of Compliance with Standards of Practice
Favorite
12:00 PM – 1:00 PM
(7-300) Milrinone Against Dobutamine Novel Assessment of Side Effects in the Treatment of Cardiogenic Shock in Patients with Heart Failure with Reduced Ejection Fraction
Favorite
12:00 PM – 1:00 PM
(7-301) Use of ChatGPT Among Healthcare Professions Students at an HBCU
Favorite
12:00 PM – 1:00 PM
(7-302) Knowledge and Confidence of Mpox Virus Treatment and Vaccination Among Pharmacists
Favorite
12:00 PM – 1:00 PM
(7-303) Targeted Pharmacotherapy Management of Immunoglobulin A Nephropathy: A scoping Review of Evidence
Favorite
12:00 PM – 1:00 PM
(7-305) Successful virologic suppression of HIV with crushed antiretrovirals in patient via G-tube
Favorite
12:00 PM – 1:00 PM
(7-306) Medication Optimization and Patient Education for African American Heart Failure Patients in the District of Columbia
Favorite
12:00 PM – 1:00 PM
(7-307) How does the community pharmacy type affect the perceived usefulness of the Kleinman Questions to Elicit Patients’ Health Belief during an IPPE I Community rotation?
Favorite
12:00 PM – 1:00 PM
(7-308) Does the number of prescriptions filled daily impact the perceived usefulness of Kleinman Questions to Elicit Patients’ Health Belief during an Introductory Pharmacy Practice Experience?
Favorite
12:00 PM – 1:00 PM
(7-309) Effect of Removing Race Coefficient from Glomerular Filtration Rate Estimating Equations: A Focus on Metformin and Sodium Glucose Cotransporter-2 Inhibitors Dosing and Eligibility.
Favorite
12:00 PM – 1:00 PM
(7-310) Effect of Removing Race Coefficient from Glomerular Filtration Rate Estimating Equations: A Focus on GLP 1 Agonist and DPP 4 Inhibitors Dosing and Eligibility.
Favorite
12:00 PM – 1:00 PM
(7-311) Clinical Factors Affecting the Accuracy of Glycated Hemoglobin (Hb A1c) Among African American patients: A Scoping Review of Evidence
Favorite
12:00 PM – 1:00 PM
(7-312) Linezolid-Induced Hyponatremia: A scoping review of evidence
Favorite
12:00 PM – 1:00 PM
(7-313) Assessing Students' Skills for Advanced Pharmacy Practice Experience Readiness
Favorite
12:00 PM – 1:00 PM
(7-314) Rated-R! A Case of Progressive Outer Retinal Necrosis - To Prophylax or Not?
Favorite
12:00 PM – 1:00 PM
(7-315) Comparison of Renal Function Estimators and their Impact on HIV Pharmacotherapy Eligibility: A Monte Carlo Approach
Favorite
12:00 PM – 1:00 PM
(7-316) Renal Outcomes of Sacubitril/Valsartan in Chronic Kidney Disease Patients: A Scoping Review of Evidence
Favorite
12:00 PM – 1:00 PM
(7-317) Evaluating the Safety of Empiric Piperacillin-tazobactam Therapy in Underserved, Non-Intensive Care Unit Hospitalized Patients at an Academic Medical Center.
Favorite
12:00 PM – 1:00 PM
(7-318) Performance of BioFire Blood Culture Identification 2 Panel (BCID2) in Adult Patients with Bloodstream Infection: A single center experience
Favorite
12:00 PM – 1:00 PM
(7-319) Assessing the Influence of Social Determinants of Health on Warfarin Patients' Time in Therapeutic Range
Favorite
12:00 PM – 1:00 PM
(7-320) A Review of Sublingual Buprenorphine and Naloxone Access in Community Pharmacies in an Urban Community
Favorite
12:00 PM – 1:00 PM
(7-321) Successful Intravaginal Use of Boric Acid Suppositories for Candida Glabrata Vulvovaginal Candidiasis
Favorite
12:00 PM – 1:00 PM
(7-322) A Post-evaluation Analysis to Assess Medication Therapy Management (MTM) Perceptions and MTM seeking actions after an MTM knowledge Intervention for Minority Elderly
Favorite
12:00 PM – 1:00 PM
(7-323) Analyzing the Association Between Housing Cost Burden, Homeownership, and an Individual’s Mental Health by U.S. Counties
Favorite
12:00 PM – 1:00 PM
(7-324) Comprehensive pharmacogenomic profiles in patients with sickle cell disease at an urban outpatient clinic
Favorite
12:00 PM – 1:00 PM
(7-325) Preventive Healthcare: Increasing HPV Vaccine Uptake Among Black Women Aged 18-22 at Howard University
Favorite
12:00 PM – 1:00 PM
(7-326) Development and Implementation of the First Sexual and Reproductive Health Pharmacist Consult Service at a Historically Black University
Favorite
12:00 PM – 1:00 PM
(7-327) The Association Between the Proportion of County Residents that are Black and the Availability of Mental Health Providers to Attend to Mental Distress
Favorite
12:00 PM – 1:00 PM
(7-328) Empowering African American Women: Assessing HPV Knowledge and Vaccination Attitudes among Young Black Women at Howard University
Favorite
12:00 PM – 1:00 PM
(7-329) National Pharmaceutical Association’s National Strategy to End The HIV Epidemic
Favorite
12:00 PM – 1:00 PM
(7-330) HBCU PHARMACY STUDENTS' VIEWS on EMERGENCY PREPAREDNESS POST COVID-19
Favorite
12:00 PM – 1:00 PM
(7-331) Retrospective Analysis of Outcomes of Gram-Negative Bacteremia Treatment
Favorite
12:00 PM – 1:00 PM
(7-332) Evaluating Access to the Human Papillomavirus (HPV) Vaccine in Rural Counties of West Virginia
Favorite
12:00 PM – 1:00 PM
(7-333) Correlating State Medicaid’s Negotiated Medication State Maximum Allowable Costs to Number of Products Available
Favorite
12:00 PM – 1:00 PM
(7-334) Impact of estimated vs. measured weight on the time to therapeutic unfractionated heparin level in the treatment of venous thromboembolism
Favorite
12:00 PM – 1:00 PM
(7-336) Taking an “Envirominute” in the Classroom to Consider Pharmacists’ Role in Environmental Sustainability
Favorite
12:00 PM – 1:00 PM
(7-337) Evaluation of Direct Oral Anticoagulants in the Treatment of Patients with LV Thrombus Caused by Non-ischemic Cardiomyopathy
Favorite
12:00 PM – 1:00 PM
(7-338) Characteristics of Patients Referred to a Family Medicine Pharmacist Run Clinic
Favorite
12:00 PM – 1:00 PM
(7-339) Evaluation of Infliximab and Biosimilar Utilization Across a Large Health System
Favorite
12:00 PM – 1:00 PM
(7-340) Evidence for a Between-Sex Anti-Seizure Medicine Efficacy Difference: Males Respond Better than Females, as Illustrated by Valproate Suppression and then, Elimination of, EEG Photoparoxysmal Response.
Favorite
12:00 PM – 1:00 PM
(7-341) Does Standard Regimen Ketorolac Pose a Risk of Kidney Injury? Evaluation of Inpatient Use of Ketorolac Across a Rural Health System.
Favorite
12:00 PM – 1:00 PM
(7-342) Evaluation of Hypertension Rates Among Patients Taking Select Oral Oncolytics
Favorite
12:00 PM – 1:00 PM
(7-343) Evaluation of adult heparin dosing chart implementation at a community hospital
Favorite
12:00 PM – 1:00 PM
(7-344) Impact of metoprolol succinate adjustment on the occurrence of arrhythmias in patients with acute decompensated heart failure exacerbation
Favorite
12:00 PM – 1:00 PM
(7-345) Probing the Maximal Concentration Post-Absorption of a ‘Biopharmaceutics-Classification-System-I’ Drug: Are Dual Factors, Body Posture and Sex, Both Important? Are Women and Men Really Different?
Favorite
12:00 PM – 1:00 PM
(7-346) Caffeine Eliminates the Circadian Variation Known to Occur with a Biopharmaceutics-Classification-System-I Drug: Evidence from a Retrospective Steady-State Pharmacokinetic Study in Stable, Hospitalized Pulmonary Patients.
Favorite
12:00 PM – 1:00 PM
(7-347) Improving PHQ-9 Completion Rates in a Family Medicine Practice: A Patient and Provider Perspective
Favorite
12:00 PM – 1:00 PM
(7-348) Evaluating Transitions of Care for Patients Newly Started on Warfarin within an Academic Medical Center System
Favorite
12:00 PM – 1:00 PM
(7-349) Old(er) Age Does Not Augment the Substantial Left-Lateral Decubitus Postural Effect of Drug Absorption: Evidence via a ‘Biopharmaceutics-Classification-System-I’ Drug
Favorite
12:00 PM – 1:00 PM
(7-350) Evaluation of Prescribing, Dosing, and Monitoring of Intravenous Heparin at a Community Hospital
Favorite
12:00 PM – 1:00 PM
(7-351) Does a Research Course Delivered via the Socratic Method Plus Specially-Designed Assignments Augment the Critical Thinking Skills of Pharmacy Students?
Favorite
12:00 PM – 1:00 PM
(7-352) Evaluation of Phytonadione Utilization in a Health System
Favorite
12:00 PM – 1:00 PM
(7-353) Sulfamethoxazole-trimethoprim dosing frequency for pneumocystis jiroveci pneumonia prophylaxis at a large academic medical center
Favorite
12:00 PM – 1:00 PM
(7-354) Evaluation of fecal microbiota transplant utilization for recurrent Clostridioides difficile infection at an academic medical center
Favorite
12:00 PM – 1:00 PM
(7-355) Analysis of the Treatment of Pain in Patients With Opioid Use Disorder (OUD) at a Rural Health System
Favorite
12:00 PM – 1:00 PM
(7-356) Evaluation of reduced alteplase dosing for catheter declotting at an academic medical center
Favorite
12:00 PM – 1:00 PM
(7-357) Evaluation of Intraoperative Methadone Use in Spinal Procedure Patients at an Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(7-358) Implementation of a Pharmacy Student Led Outpatient Parenteral Antimicrobial Therapy (OPAT) Bedside Education Service
Favorite
12:00 PM – 1:00 PM
(7-359) Evaluation of Time to First Bleed in Patients with HeartMate 3 Left Ventricular Assist Device on Aspirin
Favorite
12:00 PM – 1:00 PM
(7-360) The Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in African American Patients at an Urban Federally Qualified Health Center and Analysis of Real-World Factors
Favorite
12:00 PM – 1:00 PM
(7-361) Computer-Aided Drug Design of Histone Deacetylase Negative Allosteric Modulators as Human Immunodeficiency Virus Latency Reversal Agents
Favorite
12:00 PM – 1:00 PM
(7-362) An Evaluation of the Appropriateness of Cefdinir, Ciprofloxacin, Levofloxacin, and Cephalexin Prescribing Based on Renal Function in Oncology Clinic Patients
Favorite
12:00 PM – 1:00 PM
(7-363) Empagliflozin Induced Acute Kidney Injury Rates within Veterans 75 Years and Older
Favorite
12:00 PM – 1:00 PM
(7-364) Medication Use Evaluation of Pre and Post Hydration Comparing Normal Saline and Lactated Ringers for Cisplatin Induced Nephrotoxicity
Favorite
12:00 PM – 1:00 PM
(7-365) Patient Needs Assessment: Developing a Tailored Diabetes Self-Management Education and Support Program
Favorite
12:00 PM – 1:00 PM
(7-366) Differences in Time Spent on Work Activities and Work Characteristics Ratings in the Hospital/Health System Setting Post- COVID-19 (since March 2020)
Favorite
12:00 PM – 1:00 PM
(7-367) Measuring Pharmacist Order Verification Workload Through an Electronic Health Record at a Large Academic Medical Center Based on Pharmacological Class
Favorite
12:00 PM – 1:00 PM
(7-368) Implementation of a Student Pharmacist-led Primary Care Service to Assess Inhaler Technique in Veterans with COPD After a Device Change
Favorite
12:00 PM – 1:00 PM
(7-369) Eliminating Monitoring Time Post-Subcutaneous Daratumumab at a Large Academic Medical Center
Favorite
12:00 PM – 1:00 PM
(7-370) Slimming Down Smarter: Characterization of Weight Loss Consults to Primary Care Clinical Pharmacists in an Academic Healthcare System
Favorite
12:00 PM – 1:00 PM
(7-371) Financial and Clinical Impact of Patient Participation in Medication Assistance Programs
Favorite
12:00 PM – 1:00 PM
(7-372) Evaluation and Management of Incomplete Ovarian Function Suppression in Premenopausal Breast Cancer Patients Receiving Anti-Hormone Therapy
Favorite
12:00 PM – 1:00 PM
(7-373) Pharmacist Impact on Early Immunosuppression Withdrawal in Allogenic Hematopoietic Stem Cell Transplants
Favorite
12:00 PM – 1:00 PM
(7-374) The High Prevalence of Over-the-Counter Drug-Drug Misuse in Older Adults
Favorite
12:00 PM – 1:00 PM
(7-375) Evaluating the Efficacy of a Pharmacist-Led Intervention to Improve Hypertension Management in Primary Care at UW Health
Favorite
12:00 PM – 1:00 PM
(7-376) Improving Diabetes Outcomes Through Utilization of a Specialty Mail Service Pharmacy
Favorite
12:00 PM – 1:00 PM
(7-377) Effect of Posaconazole Dose Adjustment on Tacrolimus Levels in Cardiothoracic Transplant Recipients
Favorite
12:00 PM – 1:00 PM
(7-378) Evaluating the Safety of Iron Sucrose Intravenous Push Versus Intravenous Piggyback
Favorite
12:00 PM – 1:00 PM
(7-379) Antiplatelet and Gastrointestinal Prophylaxis Interventions in Veterans with Stable Coronary Artery Disease and Concurrent Anticoagulant Use
Favorite
12:00 PM – 1:00 PM
(7-380) Effect of Letermovir Initiation on Tacrolimus Doses in Cardiothoracic Transplant Recipients
Favorite
12:00 PM – 1:00 PM
(7-381) Introduction of Transitions of Care Pharmacy Services to the Behavioral Health Unit
Favorite
12:00 PM – 1:00 PM
(7-382) CREeping Challenges: Evaluation of Antibiotic Treatments and Clinical Outcomes in Hospitalized Patients with Ertapenem Monoresistant Carbapenem Resistant Enterobacterales (CRE) Infections
Favorite
12:00 PM – 1:00 PM
(7-383) Targeted Ambulatory Pharmacist Deprescribing for Short-term Stay Patients Upon Skilled Nursing Facility Admission
Favorite
12:00 PM – 1:00 PM
(7-384) Microbiology Nudge in The Belly: Effect of Culture Comments on Antimicrobial Prescribing for Intra-abdominal Infections
Favorite
12:00 PM – 1:00 PM
(7-385) Pharmacist-Driven Warfarin to Direct Oral Anticoagulant Transition
Favorite
12:00 PM – 1:00 PM
(7-386) Continuing Professional Development (CPD) for pharmacists at a Veterans Affairs (VA) Medical Center: a gap analysis.
Favorite
12:00 PM – 1:00 PM
(7-387) Warfarin to Direct Oral Acting Anticoagulant (DOAC) Conversion and Evaluation
Favorite
12:00 PM – 1:00 PM
(7-388) Analysis of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor and Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Use and Outcomes in Heart Transplant Recipients
Favorite
12:00 PM – 1:00 PM
(7-389) The Role of Pharmacy Students in Diabetes Education and Continuous Glucose Monitoring
Favorite
12:00 PM – 1:00 PM
(7-390) Patient/Parent-Provider Trust in Pediatric Hospitals
Favorite
12:00 PM – 1:00 PM
(7-391) Assessing the Implementation of Virtual Reality Interventions for Needle and Procedural Anxiety: A Survey
Favorite
2:00 PM – 3:30 PM
Fellows Posters
2:00 PM – 3:30 PM
(8-076) Empowering Pharmacists with AI: Chatbot for Hospital Policies
Favorite
2:00 PM – 3:30 PM
(8-077) Evaluation of Antibiotic Stewardship and Patient Outcomes for Community Acquired Pneumonia at an Academic Medical Center
Favorite
2:00 PM – 3:30 PM
(8-078) Client Satisfaction with Low-Barrier Buprenorphine Dispensing from a Mobile Medication-Assisted Recovery Unit in Chicago
Favorite
2:00 PM – 3:30 PM
(8-079) Identifying Prescribing Quantity and Trends of Potentially Inappropriate Medications in a Rural Federally Qualified Health Center Patient Centered Medical Home
Favorite
2:00 PM – 3:30 PM
(8-080) The history of amyloid targeting monoclonal antibodies and small molecules including their efficacy and safety in the treatment of Alzheimer’s disease
Favorite
2:00 PM – 3:30 PM
(8-081) Assessing the impact of antimicrobial stewardship interventions at a tertiary care university hospital in the United Arab Emirates
Favorite
2:00 PM – 3:30 PM
(8-082) Should we increase our awareness of the cadiac toxicity of osimertinib?
Favorite
2:00 PM – 3:30 PM
(8-083) Pharmaceutical Care in Critics: Analysis Of Pharmaceutical Interventions Carried Out In Two Critical Care Units
Favorite
2:00 PM – 3:30 PM
(8-084) Descriptive analysis of lung cancer clinical trials at Hospital General Universitario Gregorio Marañon
Favorite
2:00 PM – 3:30 PM
(8-085) Physicochemical stability study of furosemide in infusors using high performance liquid chromatography
Favorite
2:00 PM – 3:30 PM
(8-086) Economic Impact Assessment of Pharmaceutical Preoperative Consultations
Favorite
2:00 PM – 3:30 PM
(8-087) UF-gen: Implementation of Pharmacogenetics from a Hospital Pharmacy unit in Spain
Favorite
2:00 PM – 3:30 PM
(8-088) Real-World Effectiveness and safety of Omalizumab in patients with Chronic Idiopathic Urticaria
Favorite
2:00 PM – 3:30 PM
(8-089) Effectiveness and Safety of Risankizumab in a Case Series of Patients with Refractory Crohn's Disease: Expanding the Arsenal.
Favorite
2:00 PM – 3:30 PM
(8-090) Use of niraparib for platinum-sensitive relapsed ovarian carcinoma in real-life
Favorite
2:00 PM – 3:30 PM
(8-091) Physicochemical characterization of liquid oral formulations and review of the literature for safe and effective administration by enteral feeding tubes
Favorite
2:00 PM – 3:30 PM
(8-092) Real-life Effectiveness, Safety in Dupilumab-treated Patients with Moderate to Severe Atopic Dermatitis
Favorite
2:00 PM – 3:30 PM
(8-093) PRO PRP: Patient Reported Outcomes on Platelet-Rich Plasma
Favorite
2:00 PM – 3:30 PM
(8-094) Pharmacist Medication Reconciliation Service at Hospital Discharge: Experience of a Single Major Acute Hospital in Hong Kong
Favorite
2:00 PM – 3:30 PM
(8-095) Importance of listening to patients: results of the evaluation of patient reported outcomes in lung cancer patients.
Favorite
2:00 PM – 3:30 PM
(8-096) Assessing Economic Outcomes of Pediatric IV Antifungal Centralization
Favorite
2:00 PM – 3:30 PM
(8-097) The Impact of Fracture Risk among Patients with Asthma and Allergic Non-asthma in Taiwan: Hospital-Based Cohort Study
Favorite
2:00 PM – 3:30 PM
(8-098) Think About It: Metacognition Education and Longitudinal Exam Wrapper Reflections to Stimulate Pharmacy Student Self-Awareness Development and Exam Score Improvement
Favorite
2:00 PM – 3:30 PM
(8-099) Developing Quality Standards for Digital Therapeutic Product Labeling to Ensure Patient Safety and Therapy Efficacy
Favorite
2:00 PM – 3:30 PM
(8-100) Evaluating Diversity in Pivotal Phase 2/3 Clinical Trials for Drugs Approved by the FDA in 2023
Favorite
2:00 PM – 3:30 PM
(8-101) Evaluating Compound-Mediated Enhancement of Endosomal Trafficking for Alzheimer's Disease Therapy
Favorite
2:00 PM – 3:30 PM
(8-102) End-to-End Global Labeling, from Signal Detection to Implementation, in Delivering Up-to-Date Patient Labeling.
Favorite
2:00 PM – 3:30 PM
(8-103) Impact of Early Exposure to Pharmaceutical Industry Career Paths in PharmD Students.
Favorite
2:00 PM – 3:30 PM
(8-104) Retrospective Review of Scholarship Activities Among Post-PharmD Biopharmaceutical Industry Fellows
Favorite
2:00 PM – 3:30 PM
(8-105) Pharmacovigilance – The Full Picture of Signal Management Process
Favorite
2:00 PM – 3:30 PM
(8-106) Impact of Artificial Intelligence on the Pharmaceutical Industry and Drug Development
Favorite
2:00 PM – 3:30 PM
(8-107) The Impact of a Change From Student In-person to Remote Learning on Pharmacy Student Performance on Formative Assessments
Favorite
2:00 PM – 3:30 PM
(8-108) Opportunities to Improve upon the current landscape of well-being programs offered to pharmacy school students in the United States
Favorite
2:00 PM – 3:30 PM
(8-109) Prospective Study to Evaluate Patient-Centric Biosample Collection Using Capillary Testing Devices
Favorite
2:00 PM – 3:30 PM
(8-110) Assessing Well-Being and Willingness to Utilize Well-Being Related Resources in Pharmacy Students
Favorite
2:00 PM – 3:30 PM
(8-111) Diversity, Equity, and Inclusion Trends in Clinical Trials Reflecting Key Initiatives Set Forth by Large Pharmaceutical Companies
Favorite
2:00 PM – 3:30 PM
(8-112) Insights from a Benchmarking Survey on Compendia Communications Across Medical Information Departments
Favorite
2:00 PM – 3:30 PM
(8-113) Studying the Effects of the COVID-19 Pandemic on Post-Doctoral Fellowship Recruiting and Onboarding
Favorite
2:00 PM – 3:30 PM
(8-114) CRISPR-Cas9: A Decade of Medical Advancements and Clinical Prospects
Favorite
2:00 PM – 3:30 PM
(8-115) Tenecteplase in Acute Ischemic Stroke: Safety Considerations
Favorite
2:00 PM – 3:30 PM
(8-117) Development and assessment of an evaluation tool to appraise the quality of drug-related information in traditional news media and social media.
Favorite
2:00 PM – 3:30 PM
(8-118) Prevalence of Ingestible Sleep Therapies Accessible from the Leading Online Retailer in the United States
Favorite
2:00 PM – 3:30 PM
(8-119) Alpha-gal Syndrome (AGS) Awareness and Knowledge among Public Health Information Centers in the United States
Favorite
2:00 PM – 3:30 PM
(8-120) The Challenge of C. difficile: A Review of Disease Burden, Unmet Need and Novel Therapies in Development
Favorite
2:00 PM – 3:30 PM
(8-121) Post-Pandemic Retrospective Study of North American Pharmacist Licensure Examination (NAPLEX) Pass Rates Based on School Size and Institution Type
Favorite
2:00 PM – 3:30 PM
(8-122) Comprehensive Review of US State Regulations for Pharmacist Prescribing of Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis (PrEP) and Post-exposure Prophylaxis (PEP)
Favorite
2:00 PM – 3:30 PM
(8-123) Combination Antibiotics Use in the Pediatric Population and the Potential for Medication Errors
Favorite
2:00 PM – 3:30 PM
(8-124) Validity of ChatGPT as a Tool for Identifying and Classifying Pharmacovigilance Job Responsibilities Based on the WHO-ISoP Core Competencies
Favorite
2:00 PM – 3:30 PM
(8-125) Identifying Soft Skill Competencies in the Field of Pharmacovigilance: an Analysis of Online Job Postings
Favorite
2:00 PM – 3:30 PM
(8-126) Contributing Factors for the Career Goal Advancement of Pharmacy Learners in the Black, Indigenous, and Person of Color Community
Favorite
2:00 PM – 3:30 PM
(8-127) Evaluating the Perceived Impact of a Master of Science in Health-System Pharmacy Administration Program on Graduate Academic Success and Practice Sites
Favorite
2:00 PM – 3:30 PM
(8-128) Systems-Thinking Approach to Improving Health Literacy: An Educational Training Intervention
Favorite
2:00 PM – 3:30 PM
(8-129) Pharmacy Workshops for High School Students: Building the Next Generation of Pharmacists
Favorite
2:00 PM – 3:30 PM
(8-130) Evaluation of the Impact of Standardizing Medication Order Frequency Builds in Pharmacy Automation Systems
Favorite
2:00 PM – 3:30 PM
(8-131) The Patient Journey of Bariatric Surgery – A Study of Healthcare and Medication Utilization
Favorite
2:00 PM – 3:30 PM
(8-132) Evaluation of a health-system specialty pharmacy cardiovascular care management initiative in rheumatoid arthritis patients
Favorite
2:00 PM – 3:30 PM
(8-133) Factors Impacting Survival of Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Comparison Between Two Years and Indefinite Treatment Durations
Favorite
2:00 PM – 3:30 PM
(8-134) Racial and Ethnic Disparities in GLP-1 Receptor Agonist Prescribing for Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease
Favorite
2:00 PM – 3:30 PM
(8-135) Cross sectional evaluation of national trends in telehealth utilization using the 2021 National Health Interview Survey
Favorite
2:00 PM – 3:30 PM
(8-136) Comparing the Presence of Corporate versus Medical Social Media Accounts of Pharmaceutical Companies
Favorite
2:00 PM – 3:30 PM
Professional Posters
2:00 PM – 3:30 PM
(8-001) Financial Impact of a Zero Co-Pay Generic Pharmacy Benefit Design
Favorite
2:00 PM – 3:30 PM
(8-002) Development of a Standard Prescription Supporting Program for High-Alert Parenteral Medications to Improve Patient Safety
Favorite
2:00 PM – 3:30 PM
(8-003) System Integration of an Aligned Pharmacy and Therapeutics Committee, Policies, and Procedures Across Managed Entities
Favorite
2:00 PM – 3:30 PM
(8-004) Assessment of Hemoglobin A1C, Urine Microalbumin/creatinine, and Lipids Management in Low-Income, Uninsured Patients with Diabetes in a Community Free Clinic
Favorite
2:00 PM – 3:30 PM
(8-005) Impact of Pharmacist-Led Interventions on Deprescribing of Low-Dose Aspirin for Primary Prevention
Favorite
2:00 PM – 3:30 PM
(8-006) A Retrospective Review of Glucagon Like Peptide-1 Receptor Agonists Use and Incidence of Retinopathy in an Adult Medicine Ambulatory Care Clinic
Favorite
2:00 PM – 3:30 PM
(8-007) Student Pharmacists’ Attitudes and Knowledge of Social Determinants of Health in Ambulatory Care Experiential Setting Before and After Interprofessional Collaboration with a Community Health Worker
Favorite
2:00 PM – 3:30 PM
(8-008) Implementation of an Interprofessional Electronic Consult for the Management of Postpartum Hypertension (PPHTN)
Favorite
2:00 PM – 3:30 PM
(8-010) Evaluation of Direct Oral Anticoagulant Use in the Management of Heparin-Induced Thrombocytopenia
Favorite
2:00 PM – 3:30 PM
(8-011) Learnings from Solutions Used to Inappropriate Direct Acting Oral Anticoagulant (DOAC) Prescribing
Favorite
2:00 PM – 3:30 PM
(8-012) Charting a Sustainable Path to Safety: Celebrating 5 Years of Reduced Hospital Onset C.difficle Rates at Our Community Hospital
Favorite
2:00 PM – 3:30 PM
(8-013) Standardized Clinical Infectious Diseases Pharmacy Care Delivery and Antimicrobial Stewardship Program Management Within a Large, Integrated Healthcare System
Favorite
2:00 PM – 3:30 PM
(8-014) Shaping Psychiatric Pharmacy Through Stewardship and Standardized Outcomes
Favorite
2:00 PM – 3:30 PM
(8-015) Development of a Team-Based Clinical Pharmacy Service for Surgical Intensive Care Unit at an Academic Teaching Hospital
Favorite
2:00 PM – 3:30 PM
(8-016) Comparison of Pantoprazole Intermittent Dosing and Continuous Infusion in Suspected Upper Gastrointestinal Bleeding Prior to Endoscopy
Favorite
2:00 PM – 3:30 PM
(8-017) Safety and Effectiveness of a Standardized Intravenous Insulin Infusion Order Set for Managing Uncontrolled Hyperglycemia Outside the Intensive Care Unit
Favorite
2:00 PM – 3:30 PM
(8-019) Phenobarbital for the Treatment of Alcohol Withdrawal Clinical Practice Guideline at a Large Tertiary Healthcare System
Favorite
2:00 PM – 3:30 PM
(8-020) Can Valproic Acid Use Reduce the Need for Sedatives in Critical Care Patients?
Favorite
2:00 PM – 3:30 PM
(8-021) ChatGPT: Evaluation of Its Ability to Respond to Drug Information Questions
Favorite
2:00 PM – 3:30 PM
(8-022) Evaluation of Tolvaptan and Conivaptan Use at an Academic Medical Center
Favorite
2:00 PM – 3:30 PM
(8-023) Evaluation of Side Effect Drug Information Generated by ChatGPT
Favorite
2:00 PM – 3:30 PM
(8-024) Cost Effectiveness Analysis of the Treatment for Venomous Snake Bites in a County Health System
Favorite
2:00 PM – 3:30 PM
(8-025) Using Instagram as an Educational Platform to Provide FDA New Drug Approval Updates
Favorite
2:00 PM – 3:30 PM
(8-026) Utilization of Tetanus Vaccines in the Emergency Department
Favorite
2:00 PM – 3:30 PM
(8-027) Evaluation of Four-Factor Prothrombin Complex Concentrate (4F-PCC) Dosing Strategies for the Reversal of Bleeding Associated with Apixaban and Rivaroxaban
Favorite
2:00 PM – 3:30 PM
(8-028) Global Presence of Pharmaceuticals in the Environment: Assessing the Status of a Known Problem
Favorite
2:00 PM – 3:30 PM
(8-029) Benefits of Switching Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide up to Four Years in Patients with Chronic Hepatitis B
Favorite
2:00 PM – 3:30 PM
(8-030) Impact of Long-Term Antibiotic Monitoring on Long-Term Antibiotic Use Patterns and Overall Antibiotic Use in Hospital
Favorite
2:00 PM – 3:30 PM
(8-031) Utilization of a Smart Phrase to Decrease Unnecessary Urinalysis (UAs) in Regional Acute Care Rehabilitation Hospitals
Favorite
2:00 PM – 3:30 PM
(8-032) Effectiveness and Safety of Remdesivir in Hospitalized Patients with COVID-19 and Severe Renal Impairment
Favorite
2:00 PM – 3:30 PM
(8-034) Assessment of Ceftaroline Within a Long-Term Acute Care Hospital (LTACH) System After Implementation of a Restriction Program
Favorite
2:00 PM – 3:30 PM
(8-035) Impact of Interventions on Prescribing of Restricted Antimicrobials in a Regional Long Term Acute Care Hospital (LTACH) Market with High Baseline Utilization
Favorite
2:00 PM – 3:30 PM
(8-036) Blessed to Have This Mess: Leveraging an IV Clindamycin Shortage to Increase Use of Pre-Procedural Cefazolin in Patients with a Beta-Lactam Allergy
Favorite
2:00 PM – 3:30 PM
(8-037) Evaluation of the Impact of an Antibiotic Time-Out for Transition of IV Vancomycin to Oral Linezolid in Hospitalized Patients
Favorite
2:00 PM – 3:30 PM
(8-038) Development and Acceptance of an Electronic Tool for Requesting Medication in a Tertiary Hospital
Favorite
2:00 PM – 3:30 PM
(8-039) Implementation of a Call Center at an Academic Outpatient Pharmacy System
Favorite
2:00 PM – 3:30 PM
(8-040) Improvement of Smart Infusion Pump Interoperability in a Community Hospital
Favorite
2:00 PM – 3:30 PM
(8-041) How to Improve Smart Pump Drug Libraries with Infusion Data
Favorite
2:00 PM – 3:30 PM
(8-043) Adult 3-in-1 Parenteral Nutrition Stability with Fish Oil-Containing Lipid Injectable Emulsions
Favorite
2:00 PM – 3:30 PM
(8-044) Conversion of Custom Parenteral Nutrition to Premix Solutions in a Long-Term Acute Care Hospital
Favorite
2:00 PM – 3:30 PM
(8-045) Appropriateness of Use of Parenteral Nutrition in a Long Term Acute Care Hospital (LTACH)
Favorite
2:00 PM – 3:30 PM
(8-046) Characteristics, Prognosis and Immunotherapy Rechallenge of Patients with Immune Checkpoint Inhibitor-Related Myocarditis
Favorite
2:00 PM – 3:30 PM
(8-048) Fixed Dose 4-factor PCC for Reversal of Refractory Bleeding Associated with Cardiothoracic Surgery
Favorite
2:00 PM – 3:30 PM
(8-049) Evaluating the Role of Gabapentin in Reducing Opioid Use for Acute Pain in the Trauma Population
Favorite
2:00 PM – 3:30 PM
(8-050) Effect of a Pharmacist-Led Opioid Tapering Intervention Before Total Hip or Knee Arthroplasty: A Randomized Clinical Trial
Favorite
2:00 PM – 3:30 PM
(8-051) Limitation of Bayesian-Guided Vancomycin Monitoring in Pediatric Cancer Patients
Favorite
2:00 PM – 3:30 PM
(8-052) Prediction of Meropenem Serum Concentrations in Pediatric Septic Shock by Correlation with Renal Biomarkers and GFR Estimates
Favorite
2:00 PM – 3:30 PM
(8-053) An Outdoor Epidemic Prevention Clinic for Children and Young People with Mild or Moderate Symptoms to Obtain Medical Care During the Novel Coronavirus Outbreak
Favorite
2:00 PM – 3:30 PM
(8-054) Implementation of a Point-Based Technician Ladder Program at a Standalone-Pediatric Hospital: Challenges and Lessons Learned
Favorite
2:00 PM – 3:30 PM
(8-055) Implementation of a National Multi-Site Pharmacy Technician-in-Training Program
Favorite
2:00 PM – 3:30 PM
(8-056) Emergency Pharmacy's Mentee–Mentor Programme
Favorite
2:00 PM – 3:30 PM
(8-057) Pathways to Successful Careers in Pharmacy Administration and Leadership
Favorite
2:00 PM – 3:30 PM
(8-058) Sequential Continuing Education Curriculum Increases Confidence and Knowledge of Pharmacists Managing Triple-Negative Breast Cancer
Favorite
2:00 PM – 3:30 PM
(8-059) Comparison of Resident Strengths from Virtual versus In-Person Interviews Based on the Clifton Strengthsfinder 2.0
Favorite
2:00 PM – 3:30 PM
(8-060) Applying the DEA 3-Day Exception to Improve Methadone Access upon Hospital Discharge
Favorite
2:00 PM – 3:30 PM
(8-061) Comparison of Alteplase and Tenecteplase for Acute Ischemic Stroke Across a Healthcare System
Favorite
2:00 PM – 3:30 PM
(8-062) Influence of CYP2C19 Polymorphism on Lacosamie Pharmacokinetics in Japanese Patients with Epilepsy
Favorite
2:00 PM – 3:30 PM
(8-063) The Importance of Obtaining Baseline ECG for Patients on Qtc Prolongation Psychotropic Medications
Favorite
2:00 PM – 3:30 PM
(8-064) Knowledge, Attitude, and Practice Regarding Drug Disposal Among Patients Visiting a Tertiary Care Hospital in the United Arab Emirates
Favorite
2:00 PM – 3:30 PM
(8-065) Improvement of Prescription Review Activities by Pharmacists Before Dispensing
Favorite
2:00 PM – 3:30 PM
(8-066) Optimizing the Dispensing of Direct-Acting Antiviral Agents (DAAs) in the Illinois Department of Corrections (IDOC): An In-Depth Assessment of Policies and Procedures
Favorite
2:00 PM – 3:30 PM
(8-067) Comparison of the Bleeding Rate of Factor Xa Inhibitors in Patients with Renal Failure
Favorite
2:00 PM – 3:30 PM
(8-068) Pharmacist Contribution on an Interdisciplinary Patient Medication Education Program
Favorite
2:00 PM – 3:30 PM
(8-069) Understanding the Impact of Seizure Medication on Patient Safety: Is Greater Cardiac Monitoring Needed?
Favorite
2:00 PM – 3:30 PM
(8-070) Reducing Medication Errors: Accuracy in Reporting High Risk Medications Taken Prior to Admission
Favorite
2:00 PM – 3:30 PM
(8-071) Rural Disparities in Emergency Department Utilization for Migraine Care
Favorite
2:00 PM – 3:30 PM
(8-072) Fragility Index of Studies with Binary Outcomes Supporting Initial Approval of Orphan Drugs and Biologics
Favorite
2:00 PM – 3:30 PM
(8-073) Economic Impact of Clinical Pharmacist Interventions in an Integrated Pediatric Health System Specialty Pharmacy
Favorite
2:00 PM – 3:30 PM
(8-074) Resident Quarterly Self-Evaluation Template: Taking the Guess Work out of Evaluations
Favorite
2:00 PM – 3:30 PM
(8-075) Combating Pharmacy Staff Burnout During the COVID-19 Pandemic Through Team Building in an Inpatient Psychiatric Hospital
Favorite
